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        Abstract 
Introduction: Tuberculosis is a major global health problem worldwide. It causes ill-health 
among millions of people each year and ranks as the second leading cause of death from 
an infectious disease worldwide, after the human immune-deficiency virus. The basic 
underlying condition of any efficient allocation of resource is, knowing the financial cost of 
the disease. In Ethiopia there is a scarcity of well documented information on the costs of 
tuberculosis to patients and their families.  
Objective: To assess the cost of illness of tuberculosis to patients and their families and 
associated factors in Gondar town Health institutions, North West Ethiopia. 
Methods: A cross sectional study was undertaken from March to June 2014 in Gondar town 
health institutions. Data were collected from 245 tuberculosis patients by using a structured 
questionnaire. Numerical summary measures were used to describe the data. Binary logistic 
regression was applied to see the association of cost of illness of tuberculosis with socio- 
economic and demographic characteristics, and tuberculosis related factors. Odds ratio with 
95% confidence interval was estimated using multivariate logistic regression model to 
identify predictors of cost of illness of tuberculosis. 
Results: The mean direct and indirect cost of tuberculosis to outpatients and their families 
were 1064.90 Birr and 5142.60 Birr respectively and the mean direct and indirect cost of 
tuberculosis were 1290.10 Birr and 3154.50 Birr respectively at the time of the study. 
Educational status with AOR= 2.236, 95% CI (1.075, 5.035), visiting of other health 
providers with AOR= 0.019, 95% CI (0.002, 0.216), marital status with AOR= 0.287, 95% CI 
(0.120, 0.690) and gender with AOR= 0.180, 95% CI (0.045, 0.723) were found to be 
predictors of direct and indirect cost of tuberculosis. 
Conclusion: Costs of tuberculosis to patients and their families, especially before the 
identification of the diseases was found to be high and the costs were arising from work 
days lost, educational status of other than illiterate, marital status, care givers income lose 
due to the illness and other health providers visiting therefore consequences of Tuberculosis 
to patients and their families are serious. 
Recommendations: There should be increased focus on early diagnosis and 
treatment of tuberculosis which is imperative in limiting the spread of this highly 
infectious disease in order to minimize the costs incurred by patients and their 
families in seeking cure from their illness. 
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1.  Introduction 
Background of the study 
Tuberculosis (TB) is a chronic infectious disease that is caused by Mycobacterium 
tuberculosis, a bacterium that is spread from person to person through airborne 
particles. It is spread through the air when people who have an active TB infection 
cough, sneeze, or transmit respiratory fluids through the air. TB primarily affects the 
lungs, but it can also affect organs in the central nervous system, lymphatic system, 
and circulatory system among others (1, 2).  
Tuberculosis (TB) is a major global health problem worldwide. It causes ill-health 
among millions of people each year and ranks as the second leading cause of death 
from an infectious disease worldwide, after the human immune-deficiency virus 
(HIV) (3). 
The latest estimates included that there were 8.6 million new TB cases in 2012 and 
1.3 million TB deaths (940,000 among HIV-negative people and 320,000 among 
people who are HIV positive). This is equivalent to 14 deaths per 100,000 
populations. Among these deaths there were an estimated 170,000 from MDR-TB, a 
relatively high total compared with 450,000 incident cases of MDR-TB. In addition, 
there were an estimated 0.43 million deaths among incident TB cases that were HIV 
positive. China and India accounted for 40% of notified tuberculosis case in 2010, 
Africa accounted for 24% (4, 5, 6).  
Ethiopia is one of the 22 high burden countries (HBCs) (4).  The national population 
based TB prevalence survey conducted in 2010/11 revealed that the prevalence of 
smear positive TB among adults and all age group was found to be 108 and 63 per 
100,000 populations, respectively. The prevalence of bacteriologically confirmed TB 
was found to be 156/100,000 populations and by extrapolations, the prevalence of 
all forms of TB in Ethiopia is estimated to be 240/100,000 populations. According to 
the WHO global TB report 2012 which considered the findings from the national TB 
2 
 
prevalence survey, there were an estimated 220,000 (258 per 100,000 populations) 
incident cases of TB in Ethiopia in 2011 (6).  
Incidence of all forms of TB and bacteriologically confirmed TB in Amhara region is 
258 and 100 per 100,000 populations respectively (7). The national cure and 
treatment success rates are 67% and 84%, which is on track towards HSDP III 
target, while the case detection rate remains at 34%, far less than what was planned 
for HSDP III. Regional disaggregation showed highest Case Detection Rate in urban 
administrations (Harari 95%, Dire Dawa 81% and Addis Ababa 63%); whereas, 
Somali, Amhara and Tigray regions performed low at 19%, 23%, and 26% 
respectively (8). 
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1.1. Statement of the problem 
Tuberculosis continues to be one of the major public health problems in the world. Ethiopia 
is one of 22 countries with highest burden of tuberculosis worldwide. Tuberculosis affects 
more people aged between 15 and 49 years, most of them living in overcrowded houses (5, 
6). 
Delay in case detection and treatment may worsen the prognosis of the disease and spread 
of TB infection. Early detection and prompt treatment of infectious TB cases is important in 
order to reduce TB infection (9, 10). 
TB differs from other diseases with high mortality rates because it has a highly effective 
treatment available. The greatest burden of TB incidence and mortality is found in the 15-49 
age groups. Therefore, the economic costs of TB, in terms of lost production, are 
considerable. Medical treatment usually enables people to return to an active and 
economically productive life, often with no disability or residual morbidity. By making people 
non-infectious through medical treatment, transmission can be prevented and the global 
burden of the disease considerably reduced (11). 
Ethiopia is among countries with a high burden of tuberculosis (12). A study conducted in 
Ethiopia found that, on average, 48% of annual household income was lost due to TB 
treatment. Males have higher indirect costs (measured as loss of income) than females, 
while females incur higher direct costs than males. The cost for lower-income groups 
(<US$57.5/month) is less than for higher incomes. Patient costs per visit are high during the 
intensive phase of treatment, but declined drastically over time. In particular, indirect costs 
are high during the intensive phase. During the continuation phase, when symptoms are 
less severe, indirect costs decrease (13). Individuals who have contracted tuberculosis will 
oftentimes lose months of wages due to the inability to work and the costs associated with 
diagnosis, care, and treatment (15). 
In Ethiopia there is a scarcity of well documented information on the costs of tuberculosis to 
patients and their families even to the health care facilities. The findings of the study will 
provide valuable cost of illness information on tuberculosis to the health care planners, 
managers and the society. 
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1.2. Literature Review 
Tuberculosis affects mostly economically active population in underdeveloped and 
developing countries; therefore TB can have far reaching economic and social 
consequences among infected people and their household members (14). 
TB most frequently affects adults of working age and therefore puts families at risk 
for poverty and creates tremendous implications for gross domestic product (GDP).  
Individuals who have contracted tuberculosis will oftentimes lose months of wages 
due to the inability to work and the costs associated with diagnosis, care, and 
treatment.  Healthy family members are forced to work harder and longer in an 
attempt to make up for the financial burden of TB. If an individual succumbs to the 
illness, surviving kin face an increased risk of poverty and psychological grief or 
depression (15).  
There are several important risk factors for contracting tuberculosis including HIV 
and other immune-compromising diseases, exposure to an infected individual, 
undernourishment, overcrowding, and poor access to adequate health care facilities. 
 Many of these factors are linked to poverty and poor health systems.  Because the 
impoverished tend to live in crowded conditions, they are more at risk for contracting 
the infection.  Additionally, poverty often goes hand in hand with malnourishment, a 
problem that leads to an increased susceptibility to the disease. Immune-
compromised individuals (including those with HIV), have an increased risk of 
contracting tuberculosis (15).  
The World Health Organization (WHO) estimates that 85 per cent of TB cases occur 
in Asia and Africa (55 per cent and 30 per cent, respectively), with India and China 
alone accounting for 35 per cent of all cases. Risk factors for these TB-related 
outcomes include structures, behaviors and other diseases commonly associated 
with poverty overcrowded living or working conditions, poor nutrition, smoking, 
alcoholism, diabetes, exposure to indoor air pollution and HIV (16, 17). 
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Factors associated with costs of illness of tuberculosis 
1.2.1.  Socio – economic and Demographic factors 
                   Poverty and Cost of Tuberculosis 
TB is often known as “a disease of the poor” because the burden of TB follows a 
strong socio economic gradient both between and within countries, and also within 
the poorest communities of countries with high TB incidence. Some studies have 
shown a strong association between poverty and TB and have demonstrated that 
poor and vulnerable groups are at an increased risk of TB infection, have a higher 
prevalence of disease, have worse outcomes (including mortality), and display 
worse TB care-seeking behaviors (17). 
It is also well-known that TB can contribute to poverty by reducing patients’ physical 
strength and ability to work. However, another pathway through which TB can affect 
households’ economic situation, the costs patients incur when utilizing TB care, has 
been less studied (17).  
These costs include both direct out-of-pocket costs linked to seeking diagnosis and 
treatment including medical expenses, fees, transport, accommodation and food 
expenditures  incurred when seeking treatment and care and the Indirect 
(opportunity) costs which differ from financial cost and include the cost of foregone 
income due to the inability to work because of the illness and loss of time due to 
visits to health facilities, time spent on the road to and at health facilities, lost 
productivity and loss of job associated with utilizing health- care (18). 
1.2.2.  Expenditure, Income, Delay and Cost of TB  
Longer patient delays between first experience of symptoms and first health service 
encounter were also associated with higher costs. A possible explanation may be 
that those who delay in presenting to the health centre are more ill than those who 
present for earlier consultation, and therefore incur higher related treatment costs 
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(19). Direct medical expenditures ranged from between 10% of mean monthly 
income (MMI) for men and 132% of MMI for women in Zambia to 31% for all patients 
in Ethiopia, while non-medical expenditures ranged from 42% in Ethiopia to 55% of 
MMI in Zambia. In Ethiopia, 48% and 35% of annual household income was lost due 
to TB treatment and pre treatment costs, respectively. In addition, direct costs of TB 
was I$11 in Zambia and I$ 527 in Ethiopia, while indirect costs of TB was I$21 in 
Zambia and I$ 145 in Ethiopia (19, 20). 
Studies have also demonstrated a robust association between external constraints 
and patient delay. Distance from DOTS clinics (e.g. rural areas in The Gambia, 
Tanzania, Zambia) accounts for longer delay. Transportation costs (which are 
associated with distance between residence and DOTS clinics) also account for 
variations in timing of diagnosis in Zambia. Studies have found that other costs and 
financial difficulties more broadly also account for delay in China. Patients are more 
likely to delay diagnosis when they need to borrow money to get to healthcare 
services, lose daily income to attend DOTS clinics, and lack health insurance (21). 
A study conducted  in Ethiopia showed that, the median days spent for consultation 
among patients who had also sought care from alternative care providers was 9 
(mean = 14 days). Patients' mean days elapsed at alternative care providers and 
public health facilities were 5 and 3 days respectively (12).  
Forty three percent of patients were accompanied by at least one person to public 
health facilities. The unit median indirect costs for the time spent during 
consultations and travel at different care providers were $8 (mean = $31) and $0.6 
(mean = $2) respectively. The median direct costs spent for diagnosing each patient 
were: $1.4 (mean = $4) for transport, $5 for lodgings and $9 (median = $18) for 
medical care. The median total cost spent to diagnose each patient was estimated at 
$27 (mean = $59). Indirect costs, direct non-medical and direct medical constituted 
39%, 16% and 45% of the total cost respectively. The indirect and direct costs 
comprised 61% and 39% of the total cost spent to diagnose TB patient (12).  
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There have been many studies on cost-effectiveness of different TB control 
strategies, mainly investigating the costs to the health system. One of the first 
studies to comprehensively measure household costs found that the costs of an 
episode of TB in Thailand amounted to 20% of annual household income in the 
poorest third of Patients and thus were devastating. Other studies also found that 
household costs of an episode of TB were considerable ranging from $186 to $1457 
in Tanzania depending on treatment duration and around $920 in China (22). 
A study in Tajikistan founded that, the mean total household costs of an episode of 
TB were $1053. Patients reported household costs of $292 before the start of DOTS 
treatment, costs of $338 during the intensive phase, and $422 during the 
continuation phase. Thus about three fourth of costs were encountered after the 
patients were enrolled in the DOTS program. Direct costs amounted to $152, $147, 
and $97 for the period up to start of DOTS treatment, intensive phase, and 
continuation phase, respectively. Thus direct costs amounted to $396 in total over all 
periods and constituted 38% of total costs, the rest being lost income (22). 
In 2009, the Dominican Republic Ministry of Health and its partners conducted a 
study to determine the costs that TB patients incur. Direct (“out-of-pocket”) and 
indirect (opportunity) costs of new, retreatment, and MDR-TB patients before and 
during diagnosis and during treatment were investigated. This was linked to 
information on patients’ socioeconomic status, health-seeking behavior, and HIV 
status, as well as the impact of TB on the welfare of the household and found that 
the total costs of TB was amounted to a median of US$ 908 for new patients, US$ 
432 for retreatment patients, and US$ 3 557 for MDR-TB patients. The proportion of 
patients without a regular income increased from 1% to 54% because of falling ill 
with TB (23).  
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Conceptual framework 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Conceptual framework for factors affecting cost of illness of 
Tuberculosis 
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1.3. Justification of the Study 
The basic underlying condition of any efficient allocation of resource is, knowing the 
financial cost of the disease. Without analyzing the costs it is impossible to 
contemplate or improve the efficiency of disease control projects. In particular, the 
ongoing reform and decentralization processes in the health care systems of 
developing countries require precise cost information (24). On the most part, health 
care organizations use cost accounting to the estimate unit cost of their services that 
could help plan a realistic budget and price for the service (25). 
In Ethiopia there is a scarcity of well documented information on the costs of 
tuberculosis to patients and their families even to the health care facilities. The 
findings of the study will provide valuable cost of illness information on tuberculosis 
to the health care planners, managers and the society, so that they have a clear 
understanding of the diseases burden that is used in giving priority in case of 
resource allocation. It will also serve as a baseline data for further research in this 
aspect. 
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2. OBJECTIVES 
 
General Objective 
 To determine the cost of illness of tuberculosis to patients and their families 
and associated factors in Gondar town health institutions, North Gondar 
Administrative Zone, North West Ethiopia. 
  
 Specific Objectives 
 To determine the direct cost of tuberculosis to patients and their families 
 To determine the indirect cost of tuberculosis to patients and their families 
 To identify  factors associated with  cost of illness of tuberculosis to 
patients and their families 
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3.  METHODS 
 
3.1. Study Design 
A cross-sectional study was conducted on 245 study participants from March to 
June 2014 at Gondar Town health institutions, North Gondar Administrative Zone. 
3.2. Study Area 
The study was conducted in Gondar town, the capital of North Gondar 
Administrative Zone in Amhara National Regional State (ANRS), is about 738 Km 
away from Addis Ababa and is 180 Km away from Bahir Dar, the capital city of 
ANRS.  
Administratively, the town is divided into 24 kebeles (lowest administrative units). 
According to the 2005 Ethiopian fiscal year (2013) report of the zone, the projected 
population of Gondar town was estimated to be 258,178 Out of the total, the male 
population accounts for 47.3 %) and the female for 52.7%individuals. The town has 
public services like telecommunication, postal services, a 24 hours hydroelectric 
power and water supply system. The town has one hospital 8 health centers, 14 
health posts and 44 private clinics. According to Gondar town health office source, in 
2005 E.C (2013.), a total of 1022 TB cases were seen in 8 health centers including 
12 private clinics and Gondar University Hospital and more than 950 TB cases are 
receiving their treatment as outpatients. The payment scheme of the hospital and 
the health centre is free of charge for DOTS but the patient has to pay for laboratory 
tests, X-ray examination and consultation fees (26). 
3.3.  Population 
Source populations: All TB cases who were found in Gondar town.  
Study populations: All TB patients who were taking treatment as outpatient and all 
TB patients who were taking treatment as inpatient at health institutions on Gondar 
town during the study period (March- May 2014). 
12 
 
Inclusion Criteria 
TB patients who are 15 years age and above, taking treatment as new, retreated 
(patients who received second line regimen), or MDR-TB patients received 
treatment for at least one month and willing to participate.   
Exclusion Criteria 
Patients who were critically ill are excluded from the study.  
3.4. Sample Size Determination 
The number of TB cases included in the study (participants) was determined using 
single population proportion formula. The assumption in the calculation of the 
sample size is 95% confidence interval (CI), marginal error (d) of 5 %, and 10% non-
response rate 
 n = Zα 2 p (1-p)          
              d2                  
  Where, n = sample size 
                    p = 50% - taking the maximum proportion of TB cases who            
                                   were found to incur heavy expenditure seeking a diagnosis                                
                    d = assumed marginal error (5%)  
 
                n =   (1.96)2 (0.50) (0.50) = 384 
                                  (0.05)2    
Adding 10% non-response rate, the expected sample size was 422 TB cases 
(outpatient and inpatient). 
But because the study populations were less than 10,000, the sample size was 
calculated by using population correction formula 
                 nf = n/(1+(n/N)  
13 
 
Where, 
nf = desired sample size (with population <10,000) 
n = desired sample size (with population >10,000) 
N = the estimate of the population size 
nf = 422/(1+(422/1022) 
nf = 299  
Therefore, the final sample size for this study was 299   
 
3.5. Sampling Procedure 
Study participants were selected from health institutions found at Gondar town. The 
outpatient cases were selected on daily basis as they come for their treatment at 
health institutions and the inpatients were also be selected on daily basis as 
admitted to the same health institutions during the study period. Information 
regarding the costs of illness of tuberculosis was collected by asking tuberculosis 
patients, and the patients’ caretakers or families if the patients are unable to 
respond.  
Sampling Technique??? 
3.6. Variables of the study 
Dependent variable  
 Costs of Tuberculosis to patients and their families 
Independent variables 
Socio- economic and demographic factors such as: - expenditures due to illness, 
income, age, sex, education, marital status, occupation, family size, employment; 
Work days lost, distance from health facility, other health provider visiting, income 
14 
 
lost, costs for consultation, diagnosis, treatment, transport e.t.c , duration of 
treatment. 
3.7. Operational Definitions 
Direct Costs 
Direct costs of illness are expenditures in Ethiopian Birr expended by patients 
and their families for medical goods and services (e.g., medications, doctor 
visits, transportation, food, hospitalization, etc). Direct costs are further 
classified as direct medical and direct nonmedical costs. 
Low and High Costs 
Low costs are costs incurred by patients and their families which are below the 
median range and high costs are costs incurred by patients and their families which 
are above the median range. 
Indirect Costs 
Indirect Costs are costs (productivity losses) in Ethiopian birr expended or lost 
by the patients and their families, and include income losses due to lost workdays. 
Inpatient TB case 
A TB case, that has been diagnosed to have TB and is being admitted in the   
hospital for close follow-up and treatment. 
Intangible costs 
Intangible costs are costs of pain, grief and suffering and loss of leisure time. 
Outpatient TB case 
A TB case, who has been put on anti-TB treatment and is receiving his/her treatment 
on ambulatory basis i.e. who is not admitted as an inpatient TB case 
Patient delay 
The time (the number of days) between the onset of the first disease symptoms until 
first visit to qualified medical personnel or health care facility 
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Provider delay  
The time (the number of days) between the times the first visit was made to a health 
facility to the time the patient starts treatment. 
Total delay 
Is defined as the time (the number of days) from symptoms of TB to the time a 
patient is diagnosed and put on treatment. 
Tuberculosis case 
A patient who has been diagnosed as suffering from tuberculosis by a clinician and 
has been prescribed or referred to treatment 
3.8. Data collection procedures (instrument, personnel, data quality control) 
The data were collected using a structured questionnaire having three parts, the first 
containing socio-economic and demographic characteristics, the second contains 
costs of Tuberculosis before diagnosis and the third contains Costs of Tuberculosis 
after Diagnosis (after identification of the disease) and the questionnaire was 
administered by data collectors who were trained for two days for this purpose. The 
data collectors were clinical nurses. They were introduce  themselves and explained  
the  purpose  of  the  study  using  specific  statements  in a standard procedure.  
The data quality was insured by using a structured questionnaire that has been 
applied in other areas, pre-testing  the  questionnaire on  patients  from  the TB clinic 
which  were not included  in  the actual study and performing a daily check up of 
questionnaires filled by data collectors, in addition, regular  meetings were held  
between  the  data  collectors  and  the investigator in which some  issues arising  
from  interviews were discussed and decisions were reached.  
Pre-testing 
The structured questionnaire was pre-tested two weeks before the study period in 
the same health institutions on TB patients who were not participated in the actual 
study and those patients who participate in the pre-testing process were excluded by 
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asking them whether  they participate or not before and confirming their TB patient 
identity card. The pretest was done on (15)5% of the study participants and the 
questionnaire were assessed for its completeness, clarity and length.  
3.9. Data Processing and Analysis 
Data  were  checked,  coded  and  entered in to  Epi – info 3.5.1 and  were exported  
to SPSS  (Statistical Package  for Social  science)  version  20  for  analysis. Data 
entry was made by data clerk.  In the analysis, the socio-economic and demographic 
data were related with the pattern of tuberculosis in outpatient and inpatient cases 
and the direct and indirect costs incurred by patients and their families were 
estimated using the expenditures they have paid for diagnosis, treatment, drugs and 
other supplies and for transportation to health care facilities in outpatient case and 
was include expenditures during hospitalization in the case of inpatient cases.  
Percentage and numerical summary measures such as median, mean, range and 
standard deviation were used to describe the socio- economic and demographic 
characteristics of the study participants, and TB conditions.  
The costs which were incurred by patients and their families were dichotomized in to 
low costs (costs which are below the median range) and high costs (costs which are 
above the median range), then Binary logistic regression was used to see the 
association of cost of illness of tuberculosis with socio- economic and demographic 
characteristics, and tuberculosis related factors. Explanatory variables which have 
significant association with cost of illness of TB (p-value less than 0.2) in the 
bivariate binary logistic regression were entered to multivariate logistic regression 
model to identify predictors of cost of illness of TB. 
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Measurement of costs 
Traditionally, the cost of illness studies examined direct costs, indirect costs and 
intangible costs (27). Direct costs incurred by patients and their families were 
estimated using the expenditures they have paid for diagnosis, treatment, drugs and 
other supplies and for transportation to health care facilities in outpatient case and 
will include expenditures during hospitalization in the case of inpatient cases.  
Indirect costs or productivity losses are lost output due to reduced productivity 
caused by absenteeism, temporary or permanent disability and premature mortality 
due to the disease (TB). Human capital approach is a method of valuing livelihoods 
and values life as the value of forgone lost production. The loss of productivity 
associated with temporary or permanent disability was valued using gross earnings 
lost or some proportion of earnings if an individual is unable to work at full capacity. 
In practice the opportunity costs of lost productivity may be less than the gross 
earnings. Thus, indirect costs were reported as potential costs using human capital 
approach and were estimated on the basis of the loss of workdays that leads to 
inability to work for by patients and their families. These workdays were changed 
into monetary terms using the wage the patients and their families have been 
earning (28). 
Intangible costs of pain, grief, suffering and loss of leisure are very difficult to 
measure. Pain, suffering and other reductions in quality of life are intangible and, by 
definition, difficult to quantify. Strictly, the intangible effects of illness are not costs. 
They are negative benefits. Thus, as benefits are not included within the Cost of 
Illness (COI) framework, this study omitted the costs related to it (28). 
 
 
      
 
18 
 
4. Ethical consideration 
Ethical  clearance  was  obtained  from  Institute of Public Health Research Ethical  
Review  Committee  of  University  of Gondar, and permission letter was obtained 
from Gondar town health office and concerned bodies. Before enrollment, each 
eligible study participant (15 years of age and above) from TB Clinic of health 
Institutions on Gondar town was received detailed information about the study in the 
local language (Amharic) based on the information sheet, the importance of their 
participation, withdraw at any time and each volunteer was requested for written 
informed consent to give the requested information as an interview. Only participants 
who are agreed were interviewed after their full consent. Privacy and confidentiality 
of information given by each respondent was assured, including by not mentioning 
their name in any communication, (using their TB patient number). Clarifications 
were done as required. 
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5. Dissemination of results 
The  results  of  the  study  will  be  presented  to  University  of  Gondar,  College  of 
medicine and health sciences,  Institute of Public Health, Department of Health 
Service Management as part of master of public health thesis and it will also be 
shared to Amhara regional health bureau, North Gondar zone health  department, 
Gondar town health office, GUH and Concerned bodies. Efforts will be made to 
present the results on scientific conferences, Workshops facilitated by organizations 
like Ethiopian Public Health Association. A manuscript will be prepared and 
submitted for publication in an appropriate journal. 
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6. RESULT 
6.1. Socio – demographic results of the study population 
The study population included a total of 245 tuberculosis patients with a response 
rate of 81.9% from Gondar town health institutions including Gondar university 
hospital. Out of 245 cases, 213 were outpatient and the rest 32 were inpatient 
cases. Most of the study population was male which accounted for 55.5% (136 out 
of 245) of the general respondents and 53.5% (114 out of 213) of the outpatient 
cases. 
Table 1: Socio-demographic Characteristics of the Study Population, Gondar town, 
Ethiopia,  May, 2014  
 
Socio-demographic 
Characteristics 
 
 
Outpatient 
 
Inpatient 
 
 
Total 
 
Sex No % No % No % 
Male 114 53.5 22 68.8 136 55.5 
Female 99 46.5 10 31.3 109 44.5 
          Total 213 100 32 100 245 100 
Age No % No % No % 
 15 – 24 years 63 29.6 10 31.3 73 29.7 
 25 - 34 years 76 35.7 11 34.4 87 35.5 
 35 - 44 years 38 17.8 4 12.5 42 17.1 
 
  45 - 54   
  55 and above 
                   Total 
 
20 
16 
 213 
 
9.4 
7.5 
100 
 
5 
     2 
    32 
 
15.6 
6.3 
100 
 
25 
18 
245 
 
10.2 
 7.3 
100 
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Marital Status No % No % No % 
Single 109 51.2 17 53.1 126 51.4 
Married 60 28.2 8 25 68 27.7 
Separated 9 4.2 4 12.5 13 5.3 
Widowed 10 4.7 3 9.4 13 5.3 
Divorced 25 11.7 - - - - 
Total 213 100 32 100 245 100 
Educational Status No % No % No % 
Illiterate 55 25.8      11 34.4 66 26.9 
Read and Write 13 6.1 3 9.4 16 6.5 
Grade 1
st
-6
th
  42 19.7 4 12.5 46 18.7 
Grade 7
th
-8
th
  23 10.8 4 12.5 27 11 
Grade 9
th
-12
th
  52 24.4 7 21.9 59 24.1 
College/University 28 13.1 3 9.4 31 12.6 
                     Total      213 100 32 100 245 100 
Family Size No % No % No % 
1-3 99 46.5 18 56.3 117 47.7 
4-6 88 41.3 12 37.5 100 40.8 
7 and above 26 12.2 2 6.3 28 11.4 
Total 213 100 32 100 245 100 
 
 
The age distribution of the study population showed that 29.6% of outpatient and 
31.3% of the inpatient cases (29.7% of total study population) was between the ages 
of 15 and 24. The majority of the outpatient (35.7%) and the inpatient (34.4%) cases 
22 
 
were between the age of 24 and 34. Thirty five point five percent of the study 
population lies on this age group. The age of 7.3% (18) of the study population 
(7.5% (16) of outpatient and 6.3% (2) of inpatient) is 55 and above years which is 
the lowest age group. (Table 1). The mean age for outpatient cases were 32.6 + 
13.8 years and for inpatient cases was 32 + 13.2 years. 
It was found out that 51.4% of the entire study population was single while 27.7% of 
the study population was married. The result for marital status of the study 
population indicated that 51.2% of the outpatient and 53.1% of the inpatient cases 
were single (never married). Twenty eight point two percent of the outpatient and 
25% of the inpatient cases were married. The rest 20.6% of the outpatient and 
21.9% of the inpatient cases were either separated or widowed or divorced. (Table 
1). 
The study showed that larger numbers of the outpatient cases (25.8%) and of the 
inpatient cases (34.4%) were illiterate. On the contrary, 24.4% of the outpatient and 
21.9% of the inpatient cases were between grade 9th and grade 12th. In addition 
13.1% and 9.4% of the outpatient and inpatient cases were attained 
college/university education respectively. (Table 1). 
Family size of the study population showed that higher numbers of outpatients 
(46.5%) and inpatients (56.3%) had a family size of 1-3 persons per family. Forty 
one point three percent of the outpatient and 37.5% of the inpatient cases had a 
family size of 4-6, and 12.2% of the outpatient and 6.3% of the inpatient cases had a 
family size of 7 and above per family (table 1). 
6.2. Socio – economic results of the study population 
Regarding the occupation of the study population, students, government employees 
and farmers accounted for 14.6%, 8.9% and 9.4% of the outpatient cases 
respectively. Unemployed persons and daily laborers also accounted for 8% and 
17.4% of the outpatient cases respectively. Among the inpatient group, students and 
farmers also accounted for 25% and 15.6% of the inpatient cases respectively 
(Table 2). 
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In this study, 26.8% of the outpatient and 18.5% of the inpatient cases had a 
monthly family income of 100 - 800 Birr. About 50 outpatient cases (23.5%) and 6 
inpatient cases (22.2%) had a monthly family income of 801 - 1214 birr. Twenty five 
point four percent of the outpatient and 29.6% of the inpatient had a monthly family 
income of 1215 - 2000. Twenty four point four percent of the outpatient cases and 
29.6% of the inpatient cases had a monthly family income of 2,001 and above Birr. 
(Table 2). The mean monthly family income was 1637 + 850.3 Birr (median: 1350 
Birr, Range: 500-3500 Birr) for inpatient cases while it is 1726 + 2153 Birr (median 
1214 range 100 – 28,000) for outpatient cases.  
Table 2: Socio-economic Characteristics of the Study Population, Gondar 
town, May, 2014 
Socio-economic 
Characteristics 
 
   Outpatient 
 
    Inpatient 
 
     Total 
Occupation No % No % No % 
Unemployed 17 8 - - 17 6.9 
Retired 2 0.9 - -  2 0.8 
Student 31 14.6 8 25.0  56 22.9 
Sick 
Self employ buss with 
employees               
5 
2 
2.3 
0.9 
5 
- 
15.6 
- 
 10 
   2 
4.1 
0.8 
Housewife 37 17.4 3 9.4   40 16.3 
Merchant 22 10.3 1 3.1   23 9.4 
Daily Laborer 37 17.4 4 12.5   41 16.7 
Gov. employee 19 8.9 3 9.4   22 8.9 
Private employee 21 9.9 1 3.1   22 8.9 
Farmer 20 9.4 5 15.6   25 10.2 
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Self employ buss with 
no employees 
- - 2 6.3    2 0.8 
                       Total 213 100 32 100 245 100 
Monthly Family 
Income (Birr) 
 
No 
 
% 
 
No 
 
% 
 
No 
 
% 
100-800 57 26.8 5 18.3 62 25.8 
801-1214 50 23.5 6 22.2 56 23.4 
1215-2000 54 25.4 8 29.6 62 25.8 
2001 and above 52 24.4 8 29.6 60 25 
Total 213 100 27 100 240 100 
Monthly Individual 
Income (Birr) 
 
No 
 
% 
 
No 
 
% 
 
No 
 
% 
50-335 53 24.9 3 15.8 56 24.1 
336-600 56 26.3 2 10.5 58 25.1 
601-1200 55 25.8 4 21.1 59 25.4 
1201 and above 49 23 10 52.6 59 25.4 
Total 213 100 19 100 232 100 
 
Monthly Individual 
Expenditure 
 
No 
 
% 
 
No 
 
% 
 
No 
 
% 
50-255 53 24.9 4 20 57 24.5 
256-600 65 30.5 2 10 67 28.7 
601-1000 58 27.2 9 45 67 28.7 
1001 and above 37 17.4 5 25 42 18.1 
25 
 
Total 213 100 20 100 233 100 
 
 
The study also showed that 213 (100%) outpatient cases and 19 (59.4%) inpatient 
cases had their own monthly income. The mean monthly individual income for 
outpatient cases was 953.7 + 1018.6 (median: 600, range: 50-8000) Birr while the 
mean monthly individual income for inpatient cases was 817.7 + 842.1Birr. (Median 
700, range: 50-2500). Twenty four point four percent of the outpatient cases and 
15.8% of the inpatient cases had monthly individual income of 50-335 birr. Ten point 
five percent of the inpatient cases and 26.3% of the outpatient cases had a monthly 
income of 336-600 Birr. 25.8% outpatient cases and 21.1% inpatient cases had a 
monthly individual income of 601-1200 birr. Forty nine outpatient cases (23%) and 
10 inpatient cases (52.6%) cases had 1201 and above Birr monthly individual 
income (Table 2).  
 
The mean monthly family expenditure of the outpatient cases based on the response 
of the interview was 824.5 + 1,063.5 Birr (median: 824 Birr, range: 50-9,000 Birr) 
while it was 725.5 + 429.5 (median: 735 Birr, range: 50-1,500 Birr) Birr for inpatient 
cases. (Table 2). 
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6.3. Costs Incurred by Outpatient Cases before Identification of the Disease 
Out of 213 cases, 194 (91.1%) reported that they had had the signs and symptoms 
of the disease (TB) before the identification of TB. Fifty five point nine percent (119 
of 213) remained from work and 65 of 213 (30.5%) had financial/economic loss due 
to the illness. Accordingly, the mean patient delay from the onset of the disease to 
the first time the patient visits the health care facility was 94 + 196 days (median: 30 
days, range: 2 -2,190 days). On average, patients remained off from work for 
(median) 35 days (80 + 120 days, range: 1 - 730 days). The mean income loss due 
to the illness and being remained from work was (median) 1200.00 birr. (3987.9 + 
9771.8 Birr). 
One hundred thirty nine outpatient cases (65.3%) visited other health care facilities 
before they started their treatment at health institutions. The remaining 74 (34.7%) 
outpatient cases did not visited other health care facilities other than the current 
health institution as they started treatment. Based on the type of the health care 
facilities 54 (25.4%) and 82 (38.5%) outpatient cases visited private and government 
health care facilities respectively. A very small number i.e. 3 (1.4%) of outpatient 
cases visited traditional healer. The mean direct cost which includes costs for 
consultation fee, investigation, drugs, transportation and other expenditures (food 
and bed) was an average (median) of 376.( 1010.3 + 2025.9, range 3 – 13,922 Birr).  
Forty seven point nine percent (102 of 213) of the outpatient cases received care 
from their families/friends before the identification of the disease and 83 care-givers 
remained from their work for the average (median) of 15 days. (Mean 62 days and 
SD of 126, range of 1 – 725).  
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Table:3 Average(Median) Direct and Indirect Costs for the Outpatient Cases before an
d after the Identification of the Disease, Gondar Town, North Gondar, Ethiopia, 2014 
 
 
 
 
 
 
 
 
 
 
Before 
Diagnosis 
                                                     Expenditure for TB Treatment(Birr) 
Cost Category     Mean      SD   Median Minimum Maximum 
Consultation fee 436.70 1440.00 40.00 2.00 11,580.00 
Investigation  621.50 1331.30 184.00 5.00 10,000.00 
Drugs 349.90 554.80 173.00 12.00 3,000.00 
Transportation 105.50 140.70 50.00 2.00 900.00 
Other Total Costs 363.10 469.90 265.00 15.00 2.000.00 
                     Workdays lost and expenditures (Birr) by caring families and friends 
Classification    Mean SD Median Minimum Maximum 
Workdays lost ( Patient) 80.3   119.9    35  1  730 
Wage lost (Patient) 3987.90   771.80   1200.00 70  72,000 
Workdays lost( family) 62   126     15   1   725  
Wage lost (Family) 2905.80  5560.60    800.00  300.00  20,000.00 
Transportation (birr) 112.70   95.40      80.00   8.00  300.00 
 
 
 
 
 
 
 
 
 
After 
Diagnosis 
                  Number of outpatient days, outpatient visits, lost workdays and wage lost 
Classification  Mean SD Median Minimum Maximum 
Outpatient days 90.2 69.4 63 30 510 
Outpatient visits 63.1 41.4 60 5 385 
Lost workdays 52.9 81.4 30 2 720 
Wage lost 1941.50 3,125.20 840.00 98.00 18,000.00 
                             Outpatient Expenditure for TB Treatment(Birr) 
Cost Category  Mean SD Median Minimum Maximum 
Prescribed drugs 124.80 192.10 28.00 4.00 503.00 
Investigations 198.30 250.90 32.00 1.00 503.00 
Consultation fee 233.00 292.80 30.00 11.00 600.00 
Traditional medicine 406.70 687.00 10.00 10.00 1200.00 
Non-prescribed drugs 74.70 117.20 10.00 4.00 210.00 
Food 740.00 1018.20 740.00 20.00 1460.00 
Transportation 171.70 165.40 112.00 4.00 576.00 
   Wage loss, transportation cost, and other expenditures by patients’ families/friends 
Cost Category    Mean SD Median Minimum Maximum 
Wage lost 1060.00 1393.90 500.00 200.00 3500.00 
Transportation 230.80  252.20  155.00 4.00 840.00 
Other Expenditure 507.00  431.20  321.00 200.00 1000.00 
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Patients' families/friends lost wages remaining home from work to give care for the 
patients. They lost on average 800.00. (2905.8 + 5560.6 Birr, range: 300 -20,000). 
Transportation cost was 80 birr on average. (112.7 + 95.4 Birr, range: 8.00 - 300). 
Families/friends also expended much on other expenditures (food and bed) which 
amounts 260.00 on average. (363.10 + 469.90 Birr, range: 15.00 - 2000). The 
indirect cost before the identification of the disease includes wage lost by the patient 
and wage lost by their families/friends. 
 
Generally, the average total cost of treatment before the identification of the disease 
(before diagnosis) was 885.00 birr (median). 2905.2 + 7302.4Birr which include 
wages lost by the patient and their families/friends, consultation fee, investigation 
(Lab., X-ray, etc.), drugs, transportation cost and other expenditures (food and bed). 
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6.4. Costs Incurred by Outpatient Cases after Identification of the Disease 
Two hundred thirteen outpatient cases were included in the analysis of costs after 
identification of the disease/diagnosis of TB and the average days (median) for 
outpatient treatment was 63. The average outpatient visits of the patient were 60 
and lost work days and wages lost of the patient due to TB illness was an average of 
30 days and 840 birr respectively. 
Twenty three of 213 outpatient cases (10.8%) paid for treatment, prescribed drugs, 
or for tests after the identification of the disease (diagnosis of TB). See table 6. 
Costs on traditional medicine and non-prescribed drugs/medicine were not good 
indicator (representative) since the number of outpatient cases who used traditional 
medicine and non-prescribed medicine were only 3 and 3 respectively. 
Of 213 outpatient cases, 70 (32.9%) received care from their families/friends during 
their treatment (after diagnosis of TB). Of 70 care-givers, 31 (14.6%) lost their 
workdays for average of 14 days (58 + 141.7 days).  
On the average (median) the care-givers lost 500.00 birr (1060.00 + 1393.90 Birr, 
range: 200.00 - 3500.00) from lost days from work. Care-givers also expended a 
significant amount of money for transportation 155.00 birr (230.80 + 252.20 Birr, 
range 4.00 – 840.00) and for other expenditures 321.00 birr (507.00 +  431.00 Birr, 
range: 200.00 – 1000.00). 
In general, the total average expenditure of outpatient cases themselves and/or their 
families after diagnosis (during treatment follow-up) was found to be 125.00 birr 
(913.8 + 2244.20 Birr). This cost includes indirect cost (wage lost by the patients and 
their families) and direct costs (consultation fee, investigation, drugs, food and 
transportation costs). 
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6.5. Costs Incurred by Inpatient Cases before Identification/Diagnosis of TB 
Twenty nine of 32 inpatient cases responded that the diseases sign and symptom 
had been with them for average 198.9 + 202.5 days (median 120: range 16-720). 
Twenty inpatient cases (62.5%) had their own work and remained away from work 
for 203.5 + 289.9 days (median 60, range: 7-1000). Nine of 20(28.1%) inpatient 
cases lost their wage due to the illness.  
Out of 32 inpatient cases, 24 (75%) visited other health care facilities before their 
disease was identified and being hospitalized at GUH. The most frequently visited 
health care facilities were government health institutions (visited by 16 cases) and 
followed by private clinics (visited by 8 cases). The mean total direct cost which 
includes costs for consultation fee, investigation, drugs, transportation and other 
expenditure before diagnosis was   852.90 + 1123.90 (median: 564.00, range: 
20.00-4360.00) Birr. 
Out of 32 inpatient cases, 23 (71.9%) received care from their families or friends. On 
average the care-givers (families/friends) remained from work for 183.6 + 270.4 
(median: 60, range: 0-1000) days. Twenty one out of 23 caregivers (families/friends) 
lost their wages for giving care for the patient. The mean total cost incurred by the 
inpatient cases and their families/friends before the identification of the disease was 
1798.50 + 1906.80 (median; 800, range: 20-6785) Birr and includes wages lost by 
the patient and their families, costs on consultation fee, investigation, drugs, 
transportation, and other expenditures. 
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Table:4 Average (Median) Direct and Indirect Costs for the Inpatient Cases before and 
after the Identification of the Disease, Gondar Town, North Gondar, Ethiopia, 2014 
 
 
 
 
 
 
 
 
 
 
Before 
Diagnosis 
                     Complaints, Workdays lost and Wage Lost by the Inpatient Cases 
Classification  Mean SD Median Minimum Maximum 
Complaints (days) 198.9 202.5 120 16 720 
Workdays lost 203.5 289.9 60 7 1000 
Wage lost 1317..20 1164.90 1000.00 20.00 4,000.00 
                    Expenditure for TB Treatment(Birr) 
Cost Category   Mean SD Median Minimum Maximum 
Consultation fee 569.70 1243.20 70.00 7.00 3,800.00 
Investigation 542.50 421.40 450.00 80.00 1500.00 
Drugs 268.7 220.30 223.50 75.00 700.00 
Transportation  100.90 77.50 80.00 24.00 300.00 
Other expenditure 30.00  30.00 30.00 30.00 30.00 
Workdays lost, Wage lost and Expenditures by Families/Friends of Inpatient Cases 
Classification  Mean SD Median Minimum Maximum 
Workdays lost 183.6 270.4 60 0 1000 
Wage lost 1667.20 1140.90 2000.00 190.00 3130.00 
Transportation cost 138.20 166.70 85.00 20.00 600.00 
Other expenditure 1000.00 1000.00 1000.00 1000.00 1000.00 
 
 
 
 
 
After 
Diagnosis 
         Expenditure by Inpatient Cases during Hospitalization for TB Treatment(Birr 
Cost Category  Mean SD Median Minimum Maximum 
Prescribed drugs 3040.00 4186.10 3040.00 80.00 6000.00 
Investigation 860.00 1023.50 560.00 20.00 2000.00 
Payment to the Hospital 20.50 21.90 20.50 5.00 36.00 
Traditional remedies 11.00 11.00 11.00 11.00 11.00 
Non-prescribed drugs -  - - - - 
Food expenditure 150.00 150.00 150.00 150.00 150.00 
Wage Lost and Expenditure of Patient Families/friends during Hospitalization 
Cost Category  Mean SD Median Minimum Maximum 
Wage lost  2500.00 3672.00 1300.00 300.00 9000.00 
Transportation 66.60  47.50  58.00  20.00 140.00 
Other expenditure 145.00  7.10  145.00  140.00 150.00 
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6.6. Costs Incurred during Hospitalization of (after Dx)  Inpatient TB cases  
Inpatient TB cases stayed in the hospital for mean days of 75.7 + 124.4 (median: 35, 
Range: 10-660). Twenty four out of 32 (75%) inpatient cases remained from their 
work for about 77.17 + 144.4 days (median: 35, range: 15-720). 
Twenty four of 32 (75%) inpatient cases lost wages being hospitalized which 
amounts to 1825.00 + 1213.70 Birr (median: 1600, Range: 360.00-4000.00). During 
hospitalization, 9.4% (3 of 32) inpatient cases 
incurred costs for their treatment, prescribed drugs or tests. The mean total direct co
st of hospitalization was 2907.00 +4433.20 Birr (median: 565.00, Range: 136.00-
8020.00 birr) which includes costs on prescribed drugs, investigation, traditional 
remedies, non-prescribed drugs, food expenditure and payment to the hospital. 
Seventy five percent (24 of 32) inpatient cases received care from their 
families/friends while they were hospitalized. Ten care-givers (families/friends) 
remained from work to give care for the patients. Again 5 care-givers lost their wage 
as a result of lost workdays being in hospital to give care. 
The mean total cost incurred by the patients and their families during hospitalization 
was 2907.40 + 4433.20 Birr (median: 565.00, Range: 136.00-8020.00). The mean 
total cost before the identification of the disease and during hospitalization for the 
inpatient cases were 2809.40 + 2693.00 (median: 1800.00, range: 360.00-9565.00 
Birr). 
 
 
 
 
 
33 
 
Table 5: Summary of Median Direct and Indirect costs for the Outpatient and  
 Inpatient Cases before and after the Identification of the Disease, Gondar 
town, May, 2014 
Cost Category Outpatient Cases Inpatient Cases 
Before 
Diagnosis 
After 
Diagnosis 
Total Before 
Diagnosis 
After 
Diagnosis 
Total 
Direct cost 376.00 249.00 376.00 564.00 565.00  585.00 
Indirect Cost 1200.00 870.00 2100.00 1550.00 1600.00 2550.00 
Total 885.00 125.00 1219.00 800.00 1800.00  2562.50 
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Binary and Multivariate logistic regression for Direct Cost of Tuberculosis 
The binary logistic regression showed that direct cost of tuberculosis had significant 
association with Educational status, marital status, family size, family income, other 
health provider visiting, patient work days lost, family work days lost and payment for 
treatment and drugs.  
In the multivariate logistic regression, family work days lost, marital status, family 
size, family income, patient work days lost and payment for treatment and drugs 
were not significantly associated with direct cost of TB. Educational status and other 
health providers visiting were significantly associated with direct cost of Tuberculosis 
in the multivariate logistic regression and became predictors of direct cost of 
tuberculosis. 
Individuals (patients) who had not visited other health providers were 98.1% less 
likely to incur direct cost of Tuberculosis (AOR = 0.019, 95% CI = 0.002 to 0.216) 
than patients who had visited other health providers. 
Patients families who had an educational status of at least read and write were 
2.236 times more likely to incur direct cost of Tuberculosis (AOR = 2.236, 95% CI = 
1.075 to 5.035) than patients who were illiterate.  
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Table 6: Factors associated with Direct Cost of Tuberculosis, Gondar town, 
Ethiopia, May 2014 
   
          Variables 
Direct 
cost of 
TB 
 
Sig 
 
COR (95% CI) 
 
AOR (95% CI) 
No Yes 
        Family Size  
1 – 5 family member 72 101  1        1 
 >6 family member     12 28 0.178 1.663(0.793, 3.489) 0.512(0.094, 2.775) 
       Marital Status  
Single 48 61 0.356 1        1 
Married 20 40 0.176 1.574(0.816, 3.025) 1.192(0.301, 4.717) 
Others(separated, widowed, divorced) 16 28 0.385 1.377(0.669, 2.833) 6.025(0.642, 56.542) 
        Educational Status 
Illiterate 28 27  1        1 
At least read and write 56 102 0.045 1.889(1.015, 3.515) 2.236(1.075, 5.035) 
       Family Income  
100 – 800 Birr 26 31 0.053 1        1 
801 – 1214 Birr 25 25 0.651 0.839(0.392, 1.790) 0.136(0.013, 1.387) 
1215 – 2000 Birr 20 34 0.360 1.426(0.667, 3.04) 0.305(0.036, 2.579) 
    >2001 13 39 0.027 2.516(1.113, 5.68) 2.313(0.267, 20.001) 
     Other health provider visiting 
Yes 22 117  1        1 
No 62 12 0.000 0.036(0.017, 0.078) 0.019(0.002, 0.216) 
    Family work days lost 
No family looked 14 29 0.027 1        1 
Less or equal to 15 days 10 31 0.409 1.497(0.575, 3.895) 0.335(0.063, 1.766) 
Greater or equal to 16 days 60 69 0.112 0.555(0.269, 1.147) 0.274(0.036, 2.110) 
     Patient work days lost  
Less or equal to 30 days 62 104  1        1 
Greater or equal to 31 days 22 25 0.243 0.677(0.352,1.302)  0.607(0.100, 3.679) 
N: B: Only bold variables are significant in multivariate logistic regression 
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Binary and Multivariate logistic regression for Indirect Cost of Tuberculosis 
The binary logistic regression showed that the indirect cost of tuberculosis had 
significant association with age, gender, educational status, marital status, family 
size, family income, and family support, patient work days lost before and after the 
identification of tuberculosis.  
In the multivariate logistic regression, age, family size, family income, and family 
support, patient work days lost before and after the identification of tuberculosis 
were not found significant. Educational status, marital status and gender were 
significantly associated with indirect cost of tuberculosis and became predictors of 
indirect cost of tuberculosis. 
Patients who had an educational status of at least read and write were 2.685 times 
more likely to incur indirect cost of Tuberculosis (AOR = 2.685, 95% CI = 1.173 to 
6.147) than patients who were illiterate.   
Females were 82% less likely to incur Indirect cost of tuberculosis (AOR = 0.180, CI 
= 0.045 to 0.725) compared to males. Married patients were 71.3% less likely to 
incur indirect cost of tuberculosis (AOR = 0.287, CI = 0.120, 0.690) compared to 
single or never married. 
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Table 7: Factors associated with Indirect Cost of Tuberculosis, Gondar town, 
Ethiopia, May 2014 
 
             Variables 
Indirect 
cost of TB 
 
    Sig 
 
    COR(95% CI 
 
    AOR(95% CI) 
  
       Sex 
Male 60 54            1          1 
Female 71 28 0.050 0.438(0.247, 0.776) 0.180(0.045, 0.723) 
       Age 
15 – 24 42 21 0.082           1            1 
25 – 34 38 38 0.049 2.000(1.003, 3.989) 2.499(1.086, 5.751) 
35 – 44 27 11 0.646 0.815(0.340, 1.955) 1.571(0.527, 4.681) 
  >45 years 24 12 1.000 1.000(0.420, 2.384) 1.767(0.537, 5.815) 
     Marital status                 
Single 58 51 0.013             1            1 
Married 46 14 0.003 0.346(0.351, 0.702) 0.287(0.120, 0.690) 
Others (separated, widowed, divorced) 27 17 0.359 0.716(0.351, 1.462) 0.605(0.245, 1.499) 
     Educational status 
Illiterate 44 11              1            1 
At least read and write 87 71 0.002 3.264(1.571, 6.783) 2.685(1.173, 6.147) 
     Family size 
1 – 5 family member 103 70              1            1 
 >6 family member 28 12 0.223 0.631(0.300, 1.323) 0.787(0.334, 1.853) 
     Family income 
100 – 800 Birr 28 29 0.098              1            1 
801 – 1214 Birr 35 15 0.030 0.414(0.186, 0.918) 0.395(0.161, 0.970) 
1215 – 2000 Birr 37 17 0.040 0.444(0.205, 0.962) 0.529(0.222, 1.259) 
    >2001 31 21 0.273 0.654(0.306, 1.398) 0.525(0.221, 1.250) 
Patient work days lost before diagnosis 
Less or equal to 35 days 108 46               1          1 
Greater or equal to 36 days 23 36 0.000 3.675(1.964, 6.878) 2.200(0.943, 5.131) 
      Family support 
Yes 69 33 0.078 0.605(0.343, 1.058) 0.513(0.262, 1.005) 
No 62 49            1            1 
 Patient work days lost after diagnosis 
Less or equal to 30 days 112 54           1            1 
Greater or equal to 31 days 19 28 0.001 3.057(1.569, 5.955) 2.024(0.801, 5.113) 
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7.  DISCUSSION 
Tuberculosis affects mostly economically active population in underdeveloped and 
developing countries; therefore TB can have far reaching economic and social 
consequences among infected people and their household members (14).  
In this study, 92.5% of outpatient cases and 93.8% of inpatient cases were on the 
age group of economically productive individuals. Thus tuberculosis has the 
potential to hinder the development of both individuals and the society and therefore 
puts families at risk for poverty and creates tremendous implications for gross domestic 
product (GDP. (15). It is well known that adults aged 15 to 59 years are the most 
economically productive individuals. These age group individuals are also parents 
on whom the survival and development of children depend. This study documented 
the overall costs incurred by patients and their families.  
The study revealed that majority of the outpatient cases (25.8%) and inpatient cases 
(34.4%) were illiterate. This indicates that illiterate individuals might not have enough 
knowledge on how to prevent tuberculosis. This study showed that, an educational 
status of at least read and write contributed for patients and their families to incur 
both direct and indirect costs of tuberculosis. This might be due to, as educational 
level of an individual increases, early visiting of health facilities for health seeking 
increases and this may  lead to incur costs. 
This study showed that 60.6% of the outpatient cases incurred direct cost for TB 
treatment which was higher than a study conducted in Lusaka, Zambia (34%) and 
38.5% of the study outpatient cases incurred indirect cost for TB treatment which 
was smaller than a study conducted in Lusaka, Zambia (62%) (19), these 
differences might be due to differences in study settings or due to economical status 
of populations in which the study were conducted. 
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The study indicated that a large amount of patients and their families expenditure 
occurred before the patient was actually diagnosed and started the treatment of 
tuberculosis. The main reason for this high amount of expenditure might be the long 
period of delay from the onset of the disease to the first visit the patient made to 
health care facilities (patient delay). Longer patient delays between first experience 
of symptoms and first health service encounter were also associated with higher 
costs (19).  
The mean delay periods observed in this study was 93.5 + 195.5 days (range: 2 – 
2190) which was low compared with a study conducted in west Gojam zone, which 
was 153 + 215 days (range: 5-1,825 days) (28). It was also high compared with a 
cross-sectional survey conducted in Rungwe district, Tanzania which showed that 
the mean patient delay was 64.8 days (9); this might be due to differences in the 
design of the study or development status of the countries. 
This study showed that, both the average (median) direct and indirect costs incurred 
by inpatient cases were higher than costs incurred by outpatient cases. This was 
mainly because of hospitalization. The mean direct cost incurred by the outpatient 
cases and their families was in consistence with a study conducted in Gojjam, 
Ethiopia (28) but the mean indirect cost incurred by the outpatients and their families 
was higher than the indirect cost incurred in the previous study in Ethiopia (28) this 
could be due to differences in economical status of patients of the studies. 
In this study, an outpatient case could expend an average of a one month family 
income and an inpatient case expends an average of a two month family income for 
the diagnosis and treatment of tuberculosis. This could lead patients and their 
families to abandon other expenditures for education, shelter and other necessities. 
This again could have other implications, consequences or problems in the short-
term or long-term. 
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In this study visiting of other health providers had a significant association with direct 
cost of tuberculosis, and in outpatient cases, costs incurred by patients and their 
families before diagnosis or identification of the disease were higher than costs 
incurred after diagnosis or identification of the disease. This could be due to patient 
visits to different health care facilities in seeking cure from their illness and thus 
paying much for their treatment especially it is costly to visit private health care 
facilities in our settings (ref). In addition; this could indicate that poor detection 
system from health care facilities and delay in the identification of the disease lead to 
high economic burden and economic loss to patients and their families. 
This study showed that, majority of outpatient cases had lost less than one month of 
work and about a quarter of the outpatient cases had also  lost  more than one 
month of work before treatment of Tuberculosis. It was also found that most of the 
patients lost less than 30 days of work during treatment which was high compared to 
other study conducted in India (26%) (29), the possible reason for this might be the 
main occupation status between the study participants. 
One hundred thirty nine of 213 outpatient cases (65.2%) and 24 of 32 inpatient 
cases (75%) were found to be visited health care facilities before their disease was 
actually diagnosed/identified and started their treatment at the current health 
institution. A significant number of patients (25.4% of outpatient cases and 33.3% of 
inpatient cases), although ultimately diagnosed and treated at current public health 
facilities were found to be seeking a diagnosis in private health care facilities which 
could lead to high expenditure.  
This study showed that, female respondents which incur indirect costs were very low 
than males, this might be because of decision making power of males or because of 
high prevalence of TB in males than females. (30) 
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In recent times, economic issues have a growing importance in the health care field. 
This study clearly documented the cost of illness of tuberculosis to patients and their 
families and the resultant costs incurred by them. The results of this study may be 
used to develop new approaches for policy makers, potential donors, and health 
service personnel towards more cost-effective promotion of tuberculosis control 
programme. 
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Limitations of the Study 
 
The major limitation of the study was that the study was not a prospective study due 
to time constraints. Therefore, the data collected might not be as accurate as if it 
were prospective study i.e. there might be recall bias from participants. The other 
limitation of the study was inadequate sample size because of short data collection 
period which contributed to lose significant variables and since the inpatient cases 
were very small, they were not included in the analysis. 
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8. CONCLUSION 
The study demonstrated that among the 245 study population (154 outpatient case 
and 24 inpatient cases) in health institutions of Gondar Town, average costs of 
tuberculosis to patients and their families were very high when compared with the 
mean family monthly income. 
The study also showed that a large amount of patients and their families expenditure 
occurred before the patient was actually diagnosed and started the treatment of 
tuberculosis and also costs of tuberculosis to patients and their families were higher 
in inpatient cases than outpatients after diagnosis (during treatment) because of 
hospitalization. 
The costs of tuberculosis diagnosis incurred by patients and their families represent 
a significant portion of their monthly income. The costs arising from work days lost in 
seeking care, educational status of other than illiterate, marital status, care givers 
income lose due to the illness and other health providers visiting were major 
predictors of direct and indirect costs of tuberculosis to patients and their families.  
 
 
 
 
 
 
 
 
 
44 
 
 
9. RECOMMENDATIONS 
This study revealed that the following recommendations could be important to 
alleviate the burden of cost of tuberculosis to patients and their families:  
1. Regional health bureau or Zonal health department should train community 
health workers in rural areas to recognize the signs and symptoms of 
tuberculosis in order to refer the patient to the proper diagnostic facility 
earlier, to prevent the unnecessary spread of undiagnosed cases of TB and to 
avoid delays to reach to the health facility   
2. In health institutions, there should be increased focus on early diagnosis and 
treatment of TB which is imperative in limiting the spread of this highly 
infectious disease in order to minimize the costs incurred by patients and their 
families in seeking cure from their illness. 
3.  Advocacy, public education activities and mobilization on the symptoms of 
tuberculosis and means of prevention of the disease should be carried out 
and hence patients could seek medical service early and minimize 
unnecessary costs incurred. 
4. For researchers, prospective studies should be conducted on which patients 
are followed for an appropriate period of time which could give better estimate 
of costs incurred by patients and their families. 
5. In addition, further studies on economic burden of tuberculosis in other 
settings or areas should be conducted to strengthen the findings and to have 
a better estimate country wide. 
6. Policy makers should find solutions to decrease direct and indirect TB costs 
to prevent poverty due to TB treatment and care for those affected by the 
disease. 
 
 
. 
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                                                           ANNEX 1                    
Information Sheet and Consent Form for Cost of Illness of Tuberculosis to Patients and 
Their Families, North Gondar Zone, Amhara National Regional State, Ethiopia 
 
 
 
 
 
Name of the Principal Investigator: Fana Nigatu Yesuf    
Name of the organization: University of Gondar  
                                                  
 
Name of the Sponsor: Amhara National Regional State 
 
Information Sheet and Consent Form prepared for participants from health institutions 
of Gondar Town, North Gondar Zone, Amhara National Regional State, Ethiopia that 
studies Cost of Illness of Tuberculosis to Patients and Their Families 
 
Introduction  
This information sheet and consent form is prepared by the investigator whose main aim is to 
study the cost of illness of Tuberculosis to patients and their families in Gondar town 
health institutions, North Gondar Zone, Amhara National Regional State, Ethiopia. The 
investigator is MPH student from University of Gondar   
 
Purpose: The purpose of this research is to assess the cost of illness of Tuberculosis to 
patients and their families in Gondar town health institutions, North Gondar Zone, Amhara 
National Regional State, Ethiopia.   
Therefore, the findings of the study will provide valuable cost of illness information on 
tuberculosis to the health care planners, managers and the society, so that they have a clear 
understanding of the diseases burden that is used in giving priority in case of resource 
allocation. It will also serve as a baseline data for further research in this aspect. 
 
UNIVERSITY OF GONDAR 
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Procedure: In order to assess the cost of illness of Tuberculosis on health institutions of 
Gondar town, in North Gondar Zone, Amhara National Regional State, Ethiopia, we 
invite you to take part in our project. If you are willing to participate in our project, you need 
to understand and sign the consent form. Then, you will be asked to give your response by 
the data collectors.  For this questionnaire based study, participants are all TB patients and 
their care takers (15 years of age and above) during the study period. All the responses given 
by the participants and the results obtained will be kept anonymous and confidential using 
coding system whereby no one will have access to your responses. 
 
Risk and/or Discomfort: By participating in this research project you may feel that it has 
some discomfort specially on wasting your time (about 30-40 minutes) but this may not be 
too much as you are going to health institutions for you and your family health care and 
comparing its potential benefits it contributes to the overall improvement of the health status 
of the community. There is no risk in participating in this research project. 
 
Benefits: If you participate in this research project, you may not get direct benefit but your 
participation is likely to help us in assessing the cost of illness of Tuberculosis to patients and 
their families and in identifying factors affecting these issues on institutions of Gondar town, 
North Gondar Zone, Amhara National Regional State, Ethiopia.  
 
Incentives: You will not be provided any incentives to take part in this project. 
 
Confidentiality and Anonymity: The information that we will collect from this research 
project will be kept confidential. Information about you that will be collected from the study 
will be stored in a file, which will not have your name on it, but a code number assigned to it. 
Which number belongs to which name will be kept under lock and key, and it will not be 
revealed to anyone except the principal investigator.  
 
Right to Refuse or Withdraw: You have the full right to refuse from participating in this 
research (you can choose not to respond some or all of the questions) if you do not wish to 
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participate; and this will not affect your health services you get at from any health facilities. 
You have also the full right to withdraw from this study at any time you wish to, without 
losing any of your rights as a resident of this site. 
 
Persons to contact: If you have any question you can contact any of the following 
individuals and you may ask at any time you want. 
 
1. Fana Nigatu Yesuf: Wogera District Health Office, North Gondar Zone Health 
Department  
Tel:  +251 581 180011/ +251 918 736728 
E-mail: fananigatu@gmail.com  
 
2. Mezgebu Yitayal Mengistu: Institute of Public Health Sciences, University of Gondar 
Tel:  +251 581 116221/ + 251 920 252761  
E-mail: mezgebuy@gmail.com 
 
3. Tirsit Mehari: Institute of Public Health Sciences, University of Gondar 
Tel:  +251 581 116221/ +251 911 818622 
E-mail: tirsitmehari@gmail.com  
  
                                     
 
 
 
 
 
 
 
 
Field Code Changed
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                                                                CONSENT FORM 
 
       INFORMED CONSENT 
 
Hello.  My name is       and I am part of a team of people who are 
carrying out a study on “Cost of illness of Tuberculosis to Patients and their Families: A 
Cross-sectional Study at Health centers in Gondar town, North Gondar Administrative 
Zone`` (Show a letter of approval). We would very much appreciate your participation in this 
study.  I would like to ask you some questions and it will take about 30 minutes. Your 
answers will remain confidential, and we will not be taking down your name or address, so 
your answers will be anonymous. 
Participation in this study is voluntary and you can choose not to answer any individual 
question or all of the questions.  However, we hope that you will participate in this study 
since your views are important. 
At this time, do you want to ask me anything about the survey?   
May I begin the interview now? 
Start time:______  End time:________                 Date_____/____/_____ 
 
 
Respondent Agrees To be 
Interviewed______________1 
  
 
Respondent Does Not Agree To be 
 Interviewed _____________________2 
 
Name of Data collector: __________________       
Signature____________________ 
Name of Supervisor: ____________________        
Signature____________________                                       
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                                                            ANNEX 2 
 QUESTIONNAIRE FOR COST ESTIMATION OF OUTPATIENT TB CASES ONLY 
         Questionnaire Number: _________ 
 Patient TB Number: _________ 
 
Section1.   Socio-economic and Demographic Characteristics 
Ser. 
No 
       Questions Possible answers and coding Skip 
101 Sex 1.  Male 
2.  Female 
 
102 How old are you? 1.   ____________years 
98.  I don’t know 
99.  Refused to tell 
 
103 What is your marital 
status? 
1.  Single (never been married)  
2.  Married 
3.  Separated 
4.  Widowed 
5.  Divorced 
6.  Other (specify)_____________ 
 
104 What is your educational 
status? 
1.  Illiterate 
2.  Read and write only 
3.  Grade 1-6 (primary education) 
4.Grade 7-8 (junior secondary 
education) 
5.   Grade 9-12 (senior secondary 
education) 
6.  College, university 
7.  Other (specify)_____________ 
 
 
105 What is your religion? 1. Ethiopian Orthodox Tewahdo 
2. Muslim 
3. Catholic 
4. Protestant 
5. Other 
(specify)_________________ 
99. Refused to tell 
 
106 What is your ethnicity? 1. Amhara 
2. Tigrie 
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3. Agaw 
4. Other (specify)______________ 
99. Refused to tell 
107 What is your main 
occupation  
(Past twelve months)? 
1. Unemployed 
2.  Retired 
3.  Pupil/ student 
4. Disabled/ sick 
5.  House wife 
6.  Merchant  
7.  Daily laborer 
8.  Employed by government  
9.  Employed private for profit sector 
10.  Employed by NGO 
11. Self-employed, business with   
employees 
12.  Self-employed, business no 
employees 
13. Self-employed, farmer/ fishing 
14.  Other (specify______________ 
 
 
108 Number of people living in 
your family? 
1. ______________ 
99. Refused to tell 
 
 
 
109 How many are employed/ 
working at the moment? 
1.______________ 
99. Refused to tell 
 
 
110 What is their regular total 
monthly income? 
1.______________ 
98. I don’t know 
99.  Refused to tell 
 
 
111 What is your monthly 
income? 
1. ________Birr or ________in Kind 
98. I don’t know 
99.  Refused to tell 
 
 
112 What is your monthly 
expenditure? 
1. ________Birr or ________in Kind 
98. I don’t know 
99.  Refused to tell 
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Section2:      Costs of Tuberculosis before Diagnosis 
Ser. 
No 
Questions Possible answers and coding Skip 
201 How long did you have 
your complaints before 
becoming a patient at this 
health institution? 
1. _________ days 
98.  I don’t know 
99.  Refused to tell 
 
 
202 How many days had you 
remained from work? 
1.  _________ days 
98.  I don’t know 
99.  Refused to tell 
 
 
203 Amount of wages lost for 
days lost from work 
 
1.  __________Birr 
98.  I don’t know 
99.  Refused to tell 
 
 
204 Did you visit any other 
providers before diagnosis 
of TB? 
1.  yes 
2.  No 
If no, 
Skip to 
Q 214 
205 If yes to Q 204, number of 
health services/providers 
visited before diagnosis? 
1.  ________ 
98.  I don’t know 
99.  Refused to tell 
 
 
206 Which health services did 
you visit? 
1.  Government 
2.  NGO 
3.  Private 
4.  Traditional Healer 
5.  other (specify)_____________ 
 
 
 
 
 
 
 
 
 
207 Total cost of consultation 
fees 
 
1.  __________Birr 
98.  I don’t know 
99.  Refused to tell 
 
 
208 Total cost of Investigations 
(laboratory, X-ray, etc) 
1.  __________Birr 
98. I don’t know 
99.  Refused to tell 
 
 
 
209 Total cost of drugs 
purchased 
1.  __________Birr 
98.  I don’t know 
99.  Refused to tell 
 
210 What is the means of 
transportation to get to the 
1.  On foot 
2.  On animal Back 
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health facilities? 3 . Taxi/bus 
4.  Other(specify)_____________ 
211 How long does it take you 
to get the health services 
site? 
1. __________hours or        
 ______minutes 
98.  I don’t know 
99.   Refused to tell 
 
212 Total cost of 
Transportations 
 
1.  __________Birr 
98.  I don’t know 
99.  Refused to tell 
 
 
213 Other total costs 1.  __________ Birr 
98.  I don’t know 
99.  Refused to tell 
 
 
214 Has anyone from your 
family or friends looked 
after you prior to coming 
here? 
1.  Yes 
2.  No 
If no, skip to Q 301 
215 If yes to Q 214, number of 
days lost from work to 
accompany You? 
1.  ________ days 
98.  I don’t know 
99.  Refused to tell 
 
216 If yes to Q 214, what is 
their monthly income? 
1.  _________ Birr 
98.  I don’t know 
99.  Refused to tell 
 
217 If yes to Q 214, Do any of 
the care-givers lose any 
income because they cared 
for you?  
1.  Yes 
2.  No 
 
218 If yes to Q 214, amount of 
wages lost per days lost 
from work? 
 
1.  _________ Birr 
98.  I don’t know 
99.  Refused to tell 
 
 
 
 
 
 
219 What is the means of 
transportation for 
caregivers to get to the 
health facility? 
1.  On foot 
2.  On animal Back 
3.  Taxi/bus 
4.  Other(specify)_____________ 
 
220 How long does it take them 
to get the health services 
site? 
1.  __________hours or   
   ______minutes 
98.  I don’t know 
99.  Refused to tell 
 
221 If yes to Q 214, amount of 1.  ________ Birr  
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cost for transportation? 98.   I don’t know 
99.   Refused to tell 
 
222 If yes to Q 214, amount of 
cost for other 
expenditures? 
1.  ________ Birr 
98.  I don’t know 
99.   Refused to tell 
 
 
Section3.   Costs of Tuberculosis after Diagnosis as an Outpatient  
Ser. 
No 
Questions Possible answers and coding Skip 
301 How long have you been 
an outpatient for TB 
treatment? 
1.  ________ days 
98.  I don’t know 
99.  Refused to tell 
 
 
302 How many outpatient 
visits have you had in that 
time? 
 
1.   __________ 
98.  I don’t know 
99.  Refused to tell 
 
303 How many days have you 
remained from work being 
an outpatient? 
1.  _________ days 
98.   I don’t know 
99.   Refused to tell 
 
304 Amount of wages lost for 
days lost from work 
 
1.   __________Birr 
98.  I don’t know 
99.  Refused to tell 
 
305 Did you have to pay 
anything for your 
treatment, prescribed 
drugs or tests since you 
have been an outpatient? 
1. Yes 
2. No 
If no, skip to 315 
306 If yes, How much have you 
spent on prescribed drugs 
while you were an 
outpatient? 
1.  ___________Birr 
98.  I don’t know 
99.  Refused to tell 
 
307 If yes, How much have you 
spent on investigations 
while you were an 
outpatient? 
1.  ___________Birr 
98.  I don’t know 
99.  Refused to tell 
 
 
 
 
 
308 If yes, How much have you 
spent on other items,  
(Doctors payments, 
registration cards, clothing 
1.  ___________Birr 
98.  I don’t know 
99.  Refused to tell 
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etc)? 
309 If yes, How much have you 
spend on traditional 
medicines? 
1.   ___________Birr 
98.  I don’t know 
99.  Refused to tell 
 
310 If yes, How much have you 
spent on any other non-
prescribed remedies? 
1.  ___________Birr 
98.  I don’t know 
99.  Refused to tell 
 
311 If yes, How much have you 
or any visitors spent on 
your food?             
 
1.  ___________Birr 
98.  I don’t know 
99.  Refused to tell 
 
312 What is the means of 
transportation to get to 
the health facility (FHRH)? 
1.  On foot 
2.  On animal Back 
3.  Taxi/bus 
4.  Other(specify)___________ 
 
313 How long does it take you 
to get the health services 
site? 
1.  __________hours or   
   ______minutes 
98.  I don’t know 
99.  Refused to tell 
 
314 Total cost of 
Transportations 
 
1.  __________Birr 
98.  I don’t know 
99.  Refused to tell 
 
 
315 Has anyone from your 
family or friends looked 
after you during your 
treatment? 
1.  Yes 
2.  No 
 
316 If yes to Q 315, number of 
days lost from work to 
accompany You? 
1.  __________ days 
98.  I don’t know 
99.  Refused to tell 
 
317 If yes to Q 315, what is 
their monthly income? 
1.  _________ Birr 
98.  I don’t know 
99.  Refused to tell 
 
318 If yes to Q 315, Do any of 
the care-givers lose any 
income because they 
cared for you?  
1.  Yes 
2.  No 
 
319 If yes to Q318, amount of 
wages lost per days lost 
from work? 
1.  _________ Birr 
98.  I don’t know 
99.  Refused to tell 
 
 
 
 
320 What is the means of 1.  On foot  
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transportation for 
caregivers to get to the 
health facility? 
2.  On animal Back 
3.  Taxi/bus 
4.  Other(specify)___________ 
321 How long does it take 
them to get the health 
services site? 
1.  __________hours or   
   ______minutes 
98.  I don’t know 
99.  Refused to tell 
 
 
 
 
 
322 If yes to Q 318, amount of 
cost for transportation? 
1.  ________ Birr 
98.  I don’t know 
99.  Refused to tell 
 
323 If yes to Q 318, amount of 
cost for other 
expenditures? 
1.  ________ Birr 
98.  I don’t know 
99.  Refused to tell 
 
 
  THANK YOU FOR YOUR TIME AND COOPERATION! 
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 የምርምር/ጥናት/ ማብራሪያና የስምምነት መግሇጫ ቅጽ 
የ ምርምር ፕሮጀክቱ ርዕስ:  በአማራ ብሔራዊ ክሌሊዊ መንግስት፤  ucT@” Ô”Å` µ”&Ô”Å` Ÿ}T uT>Ñ–< Ö?“ É`Ï„‹& ¾d”v ’k`d 
uISU}™‹“ u›eታTT>­‰†¨< LÃ ¾T>ÁS×¨< ¾›=¢•T> Ý“  U” እ”ÅT>SeM  KT¨p  ¾T>Å[Ó  Ø“ƒ 
 
የ ዋና ተመራማሪ ስም: ó“ ”Ò~ ¾c<õ    
የ ድርጅቱ ስም:  ጎ ንደር ዩኒ ቨርሲቲ  ¾Ö?“ ›Övup ›=”e+ƒ¿ƒ 
የ ስፖንሰሩ ድርጅት ስም: የ አማራ ክሌሌ ጤና ቢሮ 
 
ይህ ማብራሪያና  የ ስምምነ ት መግሇጫ ቅጽ የ ተዘጋጀው Ô”Å` Ÿ}T ¬eØ vK< Ö?“ É`Ï„‹ KT>Ñ–<ƒ ¾Ø“~ }dታò­‹ c=J” Ø“~U ¾d”v ’k`d 
uISU}™‹“ u›eታTT>­‰†¨< LÃ ¾T>ÁS×¨<” ¾›=¢•T> Ý“ T¨p ’¬::   
 
መግቢያ   
የ ዚህ የ ምርምር ማብራሪያና የ ስምምነ ት ቅጽ የ ተዘጋጀዉ uጎ ንደር  ዩኒ ቨርሲቲ ¾Ö?“ ›Övup ›=”e+ƒ¿ƒ የ ድህረ  ምረቃ (›?U.ú.›?‹) 
ተማሪ  c=Jን  ዋና  አሊማዉም በአማራ ብሔራዊ ክሌሊዊ መንግስት፤  ucT@” Ô”Å` µ”&Ô”Å` Ÿ}T uT>Ñ–< Ö?“ É`Ï„‹& ¾d”v ’k`d 
uISU}™‹“ u›eታTT>­‰†¨< LÃ ¾T>ÁS×¨<” ¾›=¢•T> Ý“ T¨p ’¬::   
   
የ ምርምር ፕሮጀክቱ ዓሊማ  
የ ዚህ ጥናት ዓሊማ የ ቲቪ ህመም በጎ ንደር ከተማ በሚገ ኙ የ ቲቪ ህሙማንና በቤተሰቦቻቸዉ ሊይ የሚያመጣዉን ተጽዕኖ ማጥናት 
ሲሆን የጥናቱ ዉጤትም የቲቪ ህመም ስሇሚያሳድረዉ የኢኮኖሚ ተጽዕኖ ትክክሇኛ መረጃ ሇጤና አገልግሎት ዕቅድ ባሇሙያወች፤ሇሰራ 
አሰኪያጆች እና ሇማህበረሰቡ በመስጠት ስሇ በሽታው አሰከፊነት እና ተፅዕኖ ግልፅ የሆነ እውቅና እንዲኖራቸው በማድረግ በሀብት አመዳደብ 
ላይ ቅድሚያ እንዲሰጡ ማድረገ እንዲሁም ከዚህ በኋላ ሇሚካሄዱ ተመሳሳይ ጥናቶች እንደመነሻ መረጃ በመሆን ሊያገሇግል ይችላል፡፡ 
የ አስራር ሂደት  
በአማራ ብሔራዊ ክሌሊዊ መንግስት፤  ucT@” Ô”Å` µ”& Ô”Å` Ÿ}T uT>Ñ–< Ö?“ É`Ï„‹& ¾d”v ’k`d uISU}™‹“ u›eታTT>­‰†¨< LÃ 
¾T>ÁS×¨<” ¾›=¢•T> Ý“ KT¨p uT>"H@Å¨< Ø“ƒ LÃ እርeዎ እንዲሳተፉ ጋብዘንዎታሌ፡ ፡  በዚህ ጥናት ውስጥ ሇመሳተፍ 
ከተስማሙ ስምምነ ቱን በደንብ መረዳትና እንዲሁም መፈረም ይገ ባዎታሌ፡ ፡  ከዚያ በመቀጠሌ በጥናቱ መረጃ ሰብሳቢዎች 
ሇሚጠየ ቁት ጥያቄ እንዲመሌሱ ፈቃደኝነ ትዎ ይጠየ ቃሌ፡ ፡   
በዚህ ጥናት የ ሚሳተፉት ጤና ድርጅቶች ሊይ የ ምናገ ኛቸዉ የ ቲቪ በሽተኞችና ቤተሰቦቻቸዉ ወይም አስታማሚዎቻቸዉ ሲሆኑ 
የ ሚሠጡት መሌስም ሆነ  የ ሚገ ኘው ውጤት በT>eØር ይጠበቃሌ፡ ፡   
 
 
ሉከሰቱ የ ሚችለ ስጋቶችና ምቾት መጓደልች  
በዚህ ጥናት መሳተፍዎ ምናሌባት ጊዜዎን ሉሻማብዎ ይችሌ ይሆናሌ፡ ፡  ነ ገ ር ግን ¾Ö?“ ›ÑMÓKAƒ   KTÓ–ƒ ዘወትር ወደ 
Ö?“ ›ÑMÓKAƒ cÜ É`Ï„‹ ከመመሊሇስዎና የ ጥናቱ ውጤት ወደፊት KIw[}cu< ከሚሠጠው ጥቅም አንጻር ይህን ያህሌ አይደሇም፡ ፡  
በዚህ ጥናት በመሳተፍዎ ምንም ዓይነ ት ስጋት (ችግር) አያጋጥምዎትም፡ ፡  
 
ጥቅሞች  
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በዚህ ጥናት በመሳተፍዎ የ ተሇየ  ጥቅም አያገ ኙም፡ ፡  ነ ገ ር ግን የ እርeዎ በጥናቱ መሳተፈዎ ቀጥተኛ የ ሆነ  ጥቅም ሊያገ ኙ 
ይችሊለ ነ ገ ርግን ተሳትፎወት የ ቲቪ በሽታ በቲቪ ህሙማን እና በቤተሰቦቻቸው ሊይ የ ሚያሳድረውን የ ኢኮኖሚ ተፅ ዕኖ 
ሇተፅ ዕኖው አስተዋፅ ኦ የ ሚያደርጉ ነ ገ ሮችን ሇመሇየ ት ትሌቅ ድርሻ ይኖረዋሌ፡ ፡  
ማካካሻ  
በዚህ ጥናት በመሳተፍዎ ምንም ዓይነ ት ማካካሻ አይሠጥዎትም፡ ፡  ነ ገ ር ግን በጥናቱ በመሳተፍዎ ምስጋናችን ከፍተኛ ነ ው፡ ፡  
 
T>ስØር ስሇመጠበቅ 
ከዚህ ጥናት የ ሚገ ኝ መረጃ በሙለ በT>eØ^©’ት ይጠበቃሌ፡ ፡ . ሇዚህ ጥናት የ ሚሠበሰበ ¨< እርeዎ” የ ሚመሇከት መረጃ 
በማህደር የ ሚቀመጥ ሲሆን ማህደሩም በስUዎ ሳይሆን በተሇየ  ኮድ ሲቀመጥ ኮዱ ከዋናው ተመራማሪ ውጭ ሇማንም 
አይገ ሇጽም፡ ፡   
በጥናቱ ያሇመሳተፍ ወይም ራስን የ ማግሇሌ መብት 
በጥናቱ ሊሇመሳተፍ ከፈሇጉ በዚህ ጥናት ያሇመሳተፍ& ወይም ከአንድ በሊይ ወይም ሁለንም ጥያቄዎች አሇመመሇስ ይችሊለ፡ ፡  
በዚህ ጥናት ባሇመሳተፍዎ ወይም በከፊሌም ሆነ  በሙለ ጥያቄዎችን ባሇመመሇስዎ እ”Å ’ª]’ƒ­ ¾T>ÁÑ–<ƒን አገ ሌግልት 
አይከሇከለም፡ ፡   
 
መረጃ ሲፈሌጉ የ ሚጠይቋቸው ሰዎች   
ይህ ጥናት የ ጥናቱ ተሳታፊዎች ከጉዳት መጠበቃቸውን በሚያረጋግጠው ጎ ንደር ዩኒ ቨርሲቲ በሚገ ኘው ኮሚቴ ታይቶ ድጋፍ 
አግኝቷሌ፡ ፡  በጥናቱ ዙሪያ ማንኛውም ጥያቄ ካሇዎት ከሚከተለት ውስጥ ማንኛውንም ሠው በሚፈሇጉት ጊዜ ማነ ጋገ ር 
ይችሊለ፡ ፡   
1. ó“ ”Ò~ ¾c<õ:  ¨Ñ^ ¨[Ç Ö?“ Øun ê/u?ƒ 
      ስሌክ ቁጥር +251 58 118 0011/ +251 918 736728 
2. S´Ñu< ÃታÁM S”Óe~: Ô”Å` ¿’>y`c=+ 
      ስሌክ ቁጥር +251 58 111 6221/ +251 920 252761  
3. ƒ`c=ƒ SN]: Ô”Å` ¿’>y`c=+ 
       eM¡ lØ` :  +251 581 116221/ +251 911 818622 
 
ይህንን ቅጽ አንብበውት ከሆነ ና አሁንም ሆነ  በላሊ ጊዜ ጥያቄ የ መጠየ ቅ እድሌ ተሠጥ„ዎ ከሆነ  ወይም ይህ ቅጽ ተነ ቦና 
ተብራርቶሇዎት ከሆ’ና ሇመሳተፍ ከተስማሙ እባክዎ ስUዎንና ፊርማዎን ከዚህ በታች ያስቀምጡ፡ ፡  
የ ተሳታፊ ስም  _________________________________   
የ ስምምነ ት ተቀባይ ፊርማ ________________________  ቀን _______________  
 
ተሳታፊው ማንበብና መጻፍ የ ማይችሌ ከሆነ &  
የ ምስክር eU _____________________________________ 
የ ምስክር ፊርማ _____________________________________  ቀን _______________        
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                     ¾eUU’ƒ pê 
Ö?“ ÃeÖM˜ እ’@ eT@ ------------------------------------ ÃvLM:: uÔ”Å` Ÿ}T uT>Ñ’–< Ö?“ ×u=Á¨‹ LÃ ¾d”v 
’k`d uISU}™‹“ u›eታTT>­‰†¨< LÃ ¾T>ÁS×¨<” ¾›=¢•T> Ý“ KT¨p uT>"H@Å¨< Ø“ƒ LÃ }dታò ’˜:: 
u;=I Ø“ƒ LÃ uSd}õ­ Ÿõ}— ¾J’ ›É“qƒ Ã•[“M :: K;=I Ø“ƒ Ã[Ç” ;”É 30 Åmn ÑÅT ¾T>¨eÉ ØÁo­‹” 
MÖÃk­ƒ እðMÒKG<:: ¾T>cÖ<” SMe uUeÖ=` ¾T>Öup c=J” eU­”“ ›É^h­” uSÖÃl LÃ ›”ÖpeU::  
u;=I Ø“ƒ LÃ Sd}õ u`e­ S<K< ðnÅ˜’ƒ LÃ ¾}Sc[} c=J” ›”É ØÁo ¨ÃU G<K<”U ØÁo­‹” ›KSSKe Ã‹LK<:: ’Ñ` 
Ó” ¾እ`e­ ›e}Á¾ƒ ¨ÃU SMe ÖnT> eKJ’ uØ“~ LÃ Ãd}óK< wK” }eó •እ“Å`ÒK”:: 
›G<” eK Ø“~ T“†¨<”U ’Ñ` K=ÖÃl˜ ÃðMÒK<; 
›G<” SÖÃl” SËS` •እ‹LKG<”; 
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SËS]Á c¯ƒ --------------------- SÚ[h c¯ƒ -----------------  k” ----------------- 
 
SMe cÜ¨< (ª) KSÖÃl         SMe cÜ¨< (ª) KSÖÃl 
}eTU}ªM ---------------------  ›M}eTS<U -------------------- 
 
¾S[Í cwdu=¨< eU -------------------------------------------- ò`T ------------- 
¾}q××]¨< (ª) eU ------------------------------------------- ò`T --------------- 
 
 
 
            
           ¾d”v ’k`d IS<T” ¾SታŸT>Á Ñ”;w SÑS‰ SÖÃp 
K}SLLi ¾d”v ’k`d IS<T”•ታ"T>­‹ w‰ 
SÖÃp lØ` ----------------------------- 
¾d”v ’k`d ISU}— SKÁ lØ` ------------------------ 
 
¡õM 1 ›ÖnLÃ ¾ÓKcu< (¾ui}—¨<) S[Í 
 
101.   ïታ•:-       1. ¨”É ---------------------  2. c?ƒ ----------------------- 
102.  °ÉT@:-    1. ------------------------ ¯Sƒ  
          98. ›L¨<k¨<U -----------------------   99. SSKe ›MðMÑ<U ------- 
103. ¾Òw‰ G<’@ታ•:-  
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 1. ÁLÑv ---------------   2. ÁÑv (›wa ¾T>•`) ----------------- 
 3. }KÁÃ}¨< ¾T>•\ ------------ 4. vLD (T>e~) ¾V}uƒ --------------- 
 5. ¾}óታ(ች)• ------------------------ 6. K?L "K ÃÓKê --------------------- 
104. ¾ƒUI`ƒ G<’@ታ (ÁÖ“kk/ ÁÖ“kk‹) 
 1. ÁM}T[ -----   2. T”uw“ Síõ w‰ --------  
 3. Ÿ1— -6— ¡õM ---------  4. Ÿ7— -8— ¡õM -------  
 5. Ÿ9— - 12— ¡õM -------  6. ¢K?Ï ¿’>y`e+ -------- 
 7. K?L "K ÃÓKê ----------    
105. GÃT•ƒ­ U”É” ’¬; 
    1.*`„Ê¡e }ªIÊ 2.S<eK=U 3. ካ„K=¡ 4.ፕሮቴስታንት                                                                        
5. ላሊ ካሇ ይገ ሇጽ--------------               99. ሇመናገ ር አሌፈሇጉም 
106. የ ምን ተዎሊጅ ነ ዎት?       
          1.  አማራ           2. ትግራይ         3. አገ ዉ 
          4. ላሊ ካሇ ይገ ሇጽ --------------       99.  ሇመናገ ር አሌፈሇጉም 
107. K›Kñƒ 12 ¨^ƒ ª’— e^­ U”É” ’¨<; 
 1. e^ ›Ø ----------------        2. Ö<[}— ------------------- 
 3. }T] -----------------       4.. Se^ƒ ¾TÃ‹M / ISU}—--------- 
  5. ¾u?ƒ •እSu?ƒ -------       6. ’ÒÈ ----------    
      7. ¾k” c^}—-------                   8. ¾S”Óeƒ }k×] ----------    
      9. ¾ÓM É`Ïƒ }k×] -----           10. S.Á.É }k×] ---------- 
      11. ¾^c< É`Ïƒ c^}— ÁK<ƒ-----     12. ¾^c< É`Ïƒ c^}— ¾K?K<ƒ --- 
      13. u^c< }k×] Ñu_ /›LeÒ] ----     14. K?L "K ÃÓKê ------------- 
108. uu?}cw- ¨<eØ ¾T>Ñ–< ¾c­‹ w<ƒ:-  
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 1. ---------------- c­‹  99. S“Ñ` ›MðkÆU --------------- 
109. Ÿu?}cw­ ¨<eØ u›G<’< e”„‡ }k×] “†¨<; ¨ÃU uY^ LÃ ÃÑ—K<; 
 1. ----------------c­‹     99. S“Ñ` ›MðkÆU ------------------ 
110. ¾u?}cw­ ›ÖnLÃ ¨`G© ¾Ñu= SÖ” e”ƒ ’¨<; 
 1. --------------- w` ¨ÃU --------------- ¯Ã’ƒ  
 98. ›L¨<pU   99. S“Ñ` ›MðkÅU -------------------- 
111. ¾እ`e­ ¨`H© ¾Ñu= SÖ” e”ƒ ’¨<; 
 1. ------------ w` ¨ÃU ---------------- u¯Ã’ƒ  
 98. ›L¨<pU --------  99. S“Ñ` ›MðkÆU ---------------------- 
 
112. ¾እ`e- ¨`H© ¾¨ß SÖ” e”ƒ ’¨<; 
 1. ------------ w` ¨ÃU ---------------- u¯Ã’ƒ  
 98. ›L¨<pU --------  99. S“Ñ` ›MðkÆU ---------------------- 
 
¡õM 2   Ÿd”v ’k`d uiታ SK¾ƒ uòƒ ¾T>¨× ¾ªÒ (¾Ñ”;w) SÖ” 
201. ¾d”v ’k`d ui}— J’¨< ¨Å;=I ጤና ድርጅት ŸSU×ƒ­ uòƒ ¾ISS<  
    UM¡ƒ Ke”ƒ Ñ>;? ›w`­ƒ qÃ…M; 
 1. ------------- k“ƒ  98. ›L¨<pU ---------- 99. KS“Ñ` ›MðkÆU----- 
202. uuiታ¨< ¾}’d Ÿe^­ Ke”ƒ k“ƒ k`}ªM; 
 1. ------------- k“ƒ  98. ›L¨<pU ---------- 99. KS“Ñ` ›MðkÆU-----. 
203. uiታ¨< ŸSK¾~ uòƒ Ÿe^ Kk\v†¨< k“ƒ U” ÁIM Ñu= (uÑ”;w)  
    ›Ø}ªM; 
 1. -------------- w`  98. ›L¨<pU ---------- 99. KS“Ñ` ›MðkÆU-------- 
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204. uiታ¨< ŸSK¾~ (ŸSታ¨l) uòƒ K?L ›ÑMÓKAƒ cÜ­‹ ›Ã}­ታM;  
     ¾KU ŸJ’ ¨Å ØÁo lØ` 214 ÃH>Æ:-  
 1. ›­ -------------------  2. ¾KU -----------------  
205. KØÁo lØ` 204 SMe ›­ ŸJ’ e”ƒ ¾Ö?“ ›ÑMÓKAƒ cÜ­‹”  
    Ôw˜}ªM; 
 1. ---------------      98. ›L¨<pU ---------- 99. KS“Ñ` ›MðkÆU-------- 
206. U” ›Ã’ƒ ¾Ö?“ ›ÑMÓKAƒ cÜ É`Ïƒ Ôu–<; 
 1. ¾S”Óeƒ  2. ¾S.Á.É ----------------  3. ¾ÓM -------------- 
 4. vIL© ðªi -----      5. K?L "K ÃÑKê --------------  
207. ›ÖnLÃ ¾U¡` ›ÑMÓKAƒ ("`É ÃÚU^M) ¡õÁ  
 1. ---------- w`  98. ›L¨<pU ---------- 99. KS“Ñ` ›MðkÆU-------- 
208. ›ÖnLÃ U`S^ (Lx^„] ¨;}) ¡õÁ:- 
 1. ----------- w`  98. ›L¨<pU ---------- 99. KS“Ñ` ›MðkÆU-------- 
209. ›ÖnLÃ ¾}Ñ< SÉH’>ƒ ªÒ  
 1. ---------- w`  98. ›L¨<pU ---------- 99. KS“Ñ` ›MðkÆU-------- 
210. ¾Ö?“ É`Ï„‹ KSÉ[e U” ›Ã’ƒ ¾SÕÕ: ;È ÃÖkTK<; 
 1. uእÓ`    2. ¾እ”edƒ Ë`v (upKA' ð[e' ¨;}) 
 3. uታ¡c= / u›¨<„u=e  4. K?L "K ÃÑKê---------- 
 
211. ¾Ö?“ ›ÑMÓKAƒ cÜ¨< xታ•KSÉ[e U” ÁIM ÃðÌuዎታM; 
 1. ------ c¯ƒ ¨ÃU --------- Åmn  
      98. ›L¨<pU ----------     99. KS“Ñ` ›MðkÆU--------  
212. ›ÖnLÃ ¾SÕÕ´ ¡õÁ  
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 1 ----------- w`  98. ›L¨<pU ----------   99. KS“Ñ` ›MðkÆU-------- 
213. K?KA‹ ›ÖnLÃ ¡õÁ­‹  
 1. ----------- w`  98. ›L¨<pU ---------- 99. KS“Ñ` ›MðkÆU-------- 
214. Ÿ;=I ጤና ድርጅት ŸSU×ƒ­ uòƒ እ`Çታ•(እ”¡w"u?) ÁÅ[ÑK­ƒ u?}cw ¨ÃU ÕÅ— ›K; KØÁo lØ` 214 SMe 
¾KU ŸJ’ ¨Å ØÁo lØ` 301 ÃH>Æ 
 1. ›­   2. ¾KU --------------------    
215. KØÁo lØ` 214 SMe ›­” ŸJ’ u?}cw­ ¨ÃU ÕÅ—­ e”ƒ k”  
     Ÿእ`e- Ò` qÃ}ªM; 
 1. ----------- k“ƒ    98. ›L¨<pU ---------- 99. KS“Ñ` ›MðkÆU-------- 
216. KØÁo lØ` 214 SKe­ ›­ ŸJ’ ›ÖnLÃ ¾¨` Ñu=Á†¨< e”ƒ ’¨<; 
 1. ------------ w`    98. ›L¨<pU ---------- 99. KS“Ñ` ›MðkÆU------- 
217. KØÁo lØ` 214 SMe ›­ ŸJ’ •እ”¡w"u? ÁÅ[ÑM­ƒ u?}cw ¨ÃU ÕÅ—  
    ¾Ñu= Sk’e ‹Ó` ›ÒØTE†ªM; SMc< ¾KU ŸJ’ ¨Å ØÁo 301 ÃH>Æ 
 1. ›­ -----------   2. ¾KU -----------------  
218. KØÁo lØ` 217 SMe ›­ ŸJ’ Kk\v†¨< k“ƒ U” ÁIM ªÒ (Ñu=)  
    ›Ø}ªM; 
 1. ------------ w`  98. ›L¨<pU ---------- 99. KS“Ñ` ›MðkÆU-------- 
 
219. KØÁo lØ` 214 SMe ›­” ŸJ’ ¾Ö?“ É`Ï„‹ KSÉ[e U” ›Ã’ƒ  
    ¾SÕÕ¹ ²È ÃÖkTK<; 
 1. uእÓ`    2. ¾እ”edƒ Ë`v (upKA' ð[e' ¨;}) 
 3. uታ¡c= / u›¨<„u=e  4. K?L "K ÃÑKê---------- 
220. KØÁo lØ` 214 SMe ›­” ŸJ’ e”ƒ c¯ƒ ÃðÍM; 
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 1. ------------------ c¯ƒ ¨ÃU ----------------- Åmn 
 98. ›L¨<pU ---------- 99. KS“Ñ` ›MðkÆU--------  
221. KØÁo lØ` 217 SMe ›­ ŸJ’ KSÕÕ´ U” ÁIM Ñ”;w ›¨<Ø}ªM; 
 1. ---------- w`  98. ›L¨<pU ---------- 99. KS“Ñ` ›MðkÆU-------- 
222. KØÁo lØ` 217 SMe ›­ ŸJ’ U” ÁIM KK?KA‹ ¨Ü­‹ ›¨<Ø}ªM;  
 1. ----------- w`  98. ›L¨<pU ---------- 99. KS“Ñ` ›MðkÆU--------  
 
¡õM 3    uiታ¨<  Ÿታ¨k u%EL  }SLLi •ታ"T>­‹ ¾T>Á¨Ö<ƒ ªÒ(¾Ñ”;w)SÖ”  
301.  }SLLi ¾d”v ’k`d ታ"T> ŸJ’< ËUa e”ƒ Ñ>;? J•­ታM; 
 1. ------------k“ƒ      98. ›L¨<pU ---------- 99. KS“Ñ` ›MðkÆU------ 
302.  }ŸታታÃ I¡U“ ŸËS\ Ñ>;? ËUa e”ƒ Ñ>;? SØ}ªM; 
 1. ------------ k“ƒ     98. ›L¨<pU ---------- 99. KS“Ñ` ›MðkÆU------ 
303.  }SLLi ታ"T> uSJ”­ U¡”Áƒ Ÿe^ Ke”ƒ k“ƒ k`}ªM; 
 1. ------------ k“ƒ     98. ›L¨<pU ---------- 99. KS“Ñ` ›MðkÆU------ 
304. Ÿe^ Kk’<v†¨< k“ƒ U” ÁIM Ñu= ›Ø}ªM; 
 1. ------------ k“ƒ     98. ›L¨<pU ---------- 99. KS“Ñ` ›MðkÆU------ 
305.  }SLLi ¾d”v ’k`d ታ"T> ŸJ’<uƒ k” ËUa KI¡U“&KSÉH’>ƒ ¨ÃU  
     KU`S^ ŸõK¨< ’u`;  SMc< ¾KU ŸJ’ ¨Å ØÁo 315 ÃH>Æ:- 
 1. ›­” --------------    2. ¾KU --------------------- 
306.  KØÁo lØ` 305 SMe ›­ ŸJ’ }SLLi ታ"T> uJ’<uƒ Ñ>;? uvKS<Á  
    Kታ;; SÉH’>ƒ U” ÁIM ›¨<Ø}ªM; 
 1. --------------w`  98. ›L¨<pU ---------- 99. KS“Ñ` ›MðkÆU-------- 
307. KØÁo lØ` 305 SMe ›­ ŸJ’ }SLLi •ታŸT> uJ’<uƒ Ñ>;? KU`S^  
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     U” ÁIM ›¨<Ø}ªM; 
 1. -------------- w`   98. ›L¨<pU ----------  99. KS“Ñ` ›MðkÆU-------- 
308.  KØÁo lØ` 305 SMe­ ›­ ŸJ’ }SLLi ታ"T> uJ’<uƒ Ñ>;? KK?KA‹  
      ¨Ü­‹ (KÊ¡}` ¡õÁ' KSS´Ñu=Á "`É' KMwe ¨;}) U” ÁIM  
      ›¨<Ø}ªM; 
 1. -----------------w`  98. ›L¨<pU ---------- 99. KS“Ñ` ›MðkÆU-------- 
309. KØÁo lØ` 305 SMe ›­” ŸJ’ KvIL© SÉH’>„‹ U” ÁIM  
     ›¨<Ø}ªM 
 1. ----------------- w`  98. ›L¨<pU ---------- 99. KS“Ñ` ›MðkÆU------- 
310. KØÁo lØ` 305 SMe ›­” ŸJ’ KK?KA‹ uvKS<Á LMታ;;< SÉH’>„‹  
    (Sð¨h­‹) U” ÁIM ŸõKªM; 
 1. ----------------- w`   98. ›L¨<pU ---------- 99. KS“Ñ` ›MðkÆU------ 
311. KØÁo lØ` 305 SMe ›­” ŸJ’ እ`e­ ¨ÃU K=Ôu˜­ƒ ¾S×  
     Kእ`e¨< UÓw U” ÁIM ›¨<Ø…M:: 
 1. -------------- w`  98. ›L¨<pU ---------- 99. KS“Ñ` ›MðkÆU-------- 
312. ¾Ö?“ É`Ï„‹ KSÉ[e U” ›Ã’ƒ ¾SÕÕ: ;È ÃÖkTK<; 
 1. uእÓ`    2. ¾እ”edƒ Ë`v (upKA' ð[e' ¨;}) 
 3. uታ¡c= / u›¨<„u=e  4. K?L "K ÃÑKê---------- 
313. ¾Ö?“ ›ÑMÓKAƒ cÜ¨< xታ• KSÉ[e U” ÁIM ÃðÌxታM; 
 1. --- c¯ƒ ¨ÃU---- Åmn   98. ›L¨<pU------ 99. KS“Ñ` ›MðkÆU -----  
314. ›ÖnLÃ ¾SÕÕ´Á ¡õÁ  
 1 ----------- w`  98. ›L¨<pU ---------- 99. KS“Ñ` ›MðkÆU-------- 
315. }SLMc¨< uT>ታŸS<uƒ Ñ>;? Ÿu?}cw­ ¨ÃU ŸÕÅ˜­ Kእ`e- •እ”¡w"u?  
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    ÁÅ[Ñ ›K”;  
 1. ›­” --------------------- 2. ¾KU ---------------------- 
316. KØÁo lØ` 315 SMe ›­ ŸJ’' Ÿእ`e­ Ò` u’u\uƒ Ñ>;? Ÿe^  
     ¾k\uƒ k“ƒ w<ƒ; 
 1. ------------- k“ƒ  98. ›L¨<pU ---------- 99. KS“Ñ` ›MðkÆU-------- 
317. KØÁo lØ` 315 SMe ›­ ŸJ’' ¨`H© Ñu=Á†¨< e”ƒ ’¨<; 
 1. --------------- w`  98. ›L¨<pU ---------- 99. KS“Ñ` ›MðkÆU-------- 
318. KØÁo lØ` 315 SMe ›­ ŸJ’' Kእ`e- •እ”¡w"u? uTÉ[Ò†¨<  
    U¡”Áƒ ÁÖ<ƒ Ñu= ›K;  
 1. ›­” --------------------- 2. ¾KU ----------------------  
319. KØÁo lØ` 318 SMe ›­ ŸJ’' Kk\v†¨< k“ƒ U” ÁIM ªÒ (Ñ”;w)   
    ›Ø}ªM; 
 1. --------------- w`  98. ›L¨<pU ---------- 99. KS“Ñ` ›MðkÆU-------- 
 
320. ¾Ö?“ É`Ï„‹ KSÉ[e U” ›Ã’ƒ ¾SÕÕ: ;È ÃÖkTK<; 
 1. uእÓ`    2. ¾እ”edƒ Ë`v (upKA' ð[e' ¨;}) 
 3. uታ¡c= / u›¨<„u=e  4. K?L "K ÃÑKê---------- 
321. ¾Ö?“ ›ÑMÓKAƒ cÜ¨< xታ•KSÉ[e U” ÁIM ÃðÌxታM; 
 1.--- c¯ƒ ¨ÃU-----Åmn 98. ›L¨<pU ------ 99. KS“Ñ` ›MðkÆU------ 
322. KØÁo lØ` 318 SMe ›­ ŸJ’' KSÕÕ: U” ÁIM ›¨<Ø}ªM; 
 1. -------------- w`  98. ›L¨<pU ---------- 99. KS“Ñ` ›MðkÆU-------- 
323. KØÁo lØ` 318 SMe ›­ ŸJ’' KK?KA‹ ¨Ü­‹ U” ÁIM   
     ›¨<Ø}ªM;  
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 1. -------------- w`  98. ›L¨<pU ---------- 99. KS“Ñ` ››MðkÆU-------- 
 
           Ñ>;?­” Seª°ƒ ›É`Ñ¨< eK}vu\˜ ›ScÓ“KG<:: 
                                             ANNEX 3 
                                    CONSENT FORM 
 
       INFORMED CONSENT 
 
Hello.  My name is       and I am part of a team of people who are 
carrying out a study on “Cost of illness of Tuberculosis to Patients and their Families: A 
Cross-sectional Study at Health centers in Gondar town, North Gondar Administrative 
Zone`` (Show a letter of approval). We would very much appreciate your participation in this 
study.  I would like to ask you some questions and it will take about 30 minutes. Your 
answers will remain confidential, and we will not be taking down your name or address, so 
your answers will be anonymous. 
Participation in this study is voluntary and you can choose not to answer any individual 
question or all of the questions.  However, we hope that you will participate in this study 
since your views are important. 
At this time, do you want to ask me anything about the survey?   
May I begin the interview now? 
Start time:______  End time:________                 Date_____/____/_____ 
 
 
Respondent Agrees To be 
Interviewed______________1 
  
 
Respondent Does Not Agree To be 
 Interviewed _____________________2 
 
Name of Data collector: __________________       
Signature____________________ 
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Name of Supervisor: ____________________        
Signature____________________           
 
                                                  
                                                       ANNEX 4 
 QUESTIONNAIRE FOR COST ESTIMATION OF INPATIENT TB CASES ONLY 
         Questionnaire Number: _________ 
 Patient TB Number: _________ 
Section1. Socio-economic and Demographic Characteristics 
Ser. 
No 
Questions Possible answers and coding Skip 
101 Sex 1.Male 
2.Female 
 
102 How old are you? 1. ____________years 
98.  I don’t know 
99.  Refused to tell 
 
103 What is your marital status? 1.  Single (never been married)  
2.  Married 
3.  Separated 
4.  Widowed 
5.  Divorced 
6.  Other (specify)_____________ 
 
104 What is your educational 
status? 
1.  Illiterate 
2. Read and write only 
3. Grade 1-6 (primary education) 
4. Grade 7-8 (junior secondary 
education) 
5.  Grade 9-12 (senior secondary 
education) 
6.  College, university 
7.  Other (specify)_____________ 
 
 
105 What is your main occupation  
(Past twelve months)? 
1.  Unemployed 
2.  Retired 
3.  Pupil/ student 
4.  Disabled/ sick 
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5.  House wife 
6.  Merchant  
7.  Daily laborer 
8.  Employed by government  
9.  Employed private for profit sector 
10. Employed by NGO 
11. Self- employed, business with 
employees 
12.  Self-employed, business no 
employees 
13. Self-employed, farmer/ fishing 
14.  Other (specify______________ 
 
106 Number of people living in 
your family? 
1.  ______________ 
99.  Refused to tell 
 
 
 
107 How many are employed/ 
working at the moment? 
1.  ______________ 
99.  Refused to tell 
 
 
108 What is their regular total 
monthly income? 
1.  ______________ 
98.  I don’t know 
99.  Refused to tell 
 
 
109 What is your monthly 
income? 
1.  ________Birr or ________in Kind 
98.  I don’t know 
99.  Refused to tell 
 
 
  
   Section2: Costs of Tuberculosis before Diagnosis 
Ser. 
No 
Questions Possible answers and coding Skip 
201 How long did you have your 
complaints before becoming 
a patient at this health 
facility? 
1. _________ days 
98.  I don’t know 
99.  Refused to tell 
 
 
202 How many days had you 
remained from work? 
1.  _________ days 
98.  I don’t know 
99.  Refused to tell 
 
 
203 Amount of wages lost for 
days lost from work 
 
1.  __________Birr 
98.  I don’t know 
99.  Refused to tell 
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204 Did you visit any other 
providers before diagnosis of 
TB? 
1. yes 
2. No 
If no, 
Skip to 
Q 214 
205 If yes to Q 204, number of 
health services/providers 
visited before diagnosis? 
1.  ________ 
98.  I don’t know 
99.  Refused to tell 
 
 
206 Which health services did you 
visit? 
1.  Government 
2.  NGO 
3.  Private 
4.  Traditional Healer 
5.  other (specify)_____________ 
 
 
 
 
 
 
 
 
207 Total cost of consultation fees 
 
1.  __________Birr 
98.  I don’t know 
99.  Refused to tell 
 
 
208 Total cost of Investigations 
(laboratory, X-ray, etc) 
1.  __________Birr 
98.  I don’t know 
99.  Refused to tell 
 
 
 
209 Total cost of drugs purchased 1.  __________Birr 
98.  I don’t know 
99.  Refused to tell 
 
210 What is the means of 
transportation to get to the 
health facilities? 
1.  On foot 
2. On animal Back 
3. Taxi/bus 
4. Other(specify)_____________ 
 
211 How long does it take you to 
get the health services site? 
1.  __________hours or   
   ______minutes 
98.  I don’t know 
99.  Refused to tell 
 
212 Total cost of Transportations 
 
1.  __________Birr 
98.  I don’t know 
99.  Refused to tell 
 
 
213 Other total costs 1.  __________ Birr 
98.  I don’t know 
99.  Refused to tell 
 
 
214 Has anyone from your family 
or friends looked after you 
prior to coming here? 
1.  Yes 
2.  No 
If no, skip to Q 301 
215 If yes to Q 214, number of 
days lost from work to 
accompany You? 
1.  ________ days 
98.  I don’t know 
99.  Refused to tell 
 
216 If yes to Q 214, what is their 1.  __ _______ Birr  
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monthly income? 98.  I don’t know 
99.  Refused to tell 
217 If yes to Q 214, Do any of the 
care-givers lose any income 
because they cared for you?  
1.  Yes 
2.  No 
 
218 If yes to Q 214, amount of 
wages lost per days lost from 
work? 
 
1.  _________ Birr 
98.  I don’t know 
99.  Refused to tell 
 
 
 
 
 
 
219 What is the means of 
transportation for caregivers 
to get to the health facility? 
1.  On foot 
2.  On animal Back 
3.  Taxi/bus 
4.  Other(specify)_____________ 
 
220 How long does it take them to 
get the health services site? 
1.  __________hours or   
   ______minutes 
98.  I don’t know 
99.  Refused to tell 
 
221 If yes to Q 214, amount of 
cost for transportation? 
1.  ________ Birr 
98.  I don’t know 
99.  Refused to tell 
 
 
222 If yes to Q 214, amount of 
cost for other expenditures? 
1.  ________ Birr 
98.  I don’t know 
99.  Refused to tell 
 
 
Section3. Costs of Tuberculosis after Diagnosis as an Inpatient 
Ser. 
No 
Questions Possible answers and coding Skip 
301 How many days did you stay in 
this health facility? 
  
1. ___________ days 
98.  I don’t know 
99.  Refused to tell 
 
302 Did you have to buy anything 
special for your stay in the health 
facility (i.e. towels, home dressing 
gown, sleepers, etc.)? 
1. Yes 
2. No 
If no, skip to Q 
305 
303 If yes, How much have you 
spent? 
1.  __________ Birr 
98.  I don’t know 
99.  Refused to tell 
 
 
304 How many days have you 
remained from work being an 
inpatient? 
1.  _________ days 
98.  I don’t know 
99.  Refused to tell 
 
305 Did you lose any income as a 1.  Yes If no, skip to Q 
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result of being in the health 
facility? 
2.  No 307 
306 If yes, How much have you spent 
per days lost from work? 
 
1.  __________ Birr 
98.  I don’t know 
99.  Refused to tell 
 
307 Did you have to pay anything for 
your treatment, prescribed drugs 
or tests since being in this health 
facility? 
1.  Yes 
2.  No 
 
If no, skip to Q 
311 
308 If yes, How much have you spent 
on prescribed drugs while you 
were an inpatient? 
1.  __________ Birr 
98.  I don’t know 
99.  Refused to tell 
 
309 If yes, How much have you spent 
on investigations while you were 
an inpatient 
1.  __________ Birr 
98.  I don’t know 
99.  Refused to tell 
 
310 If yes, How much have you spent 
on other payments to the health 
institution or staff? (Doctors 
payments, registration cards, 
clothing etc)? 
1.  __________ Birr 
98.  I don’t know 
99.  Refused to tell 
 
 
 
 
311 How much have you spent on 
traditional remedies?             
1.  __________ Birr 
98.  I don’t know 
99.  Refused to tell 
 
 
312 How much on any other un-
prescribed remedies? 
 
1.  __________ Birr 
98.  I don’t know 
99.  Refused to tell 
 
313 How much have you or any 
visitors spent on your food while 
in the health facility ?             
1.  __________ Birr 
98.  I don’t know 
99.  Refused to tell 
 
314 Has anyone from your family or 
friends looked after you during 
your stay in the health facility? 
1.  Yes 
2.  No 
 
315 If yes, number of days lost from 
work to accompany You? 
1.  __________ Birr 
98.  I don’t know 
99.  Refused to tell 
 
316 If yes, what is their monthly 
income? 
1.  _________ Birr 
98.  I don’t know 
99.  Refused to tell 
 
317 If yes, Do any of the care-givers 
lose any income because they 
cared for you?  
 
1.  Yes 
2.  No 
 
 
318 If yes, amount of wages lost per 
days lost from work? 
1.  _________ Birr 
98.  I don’t know 
99.  Refused to tell 
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319 If yes, what is the means of 
transportation for caregivers to 
get to the health facility? 
1.  On foot 
2.  On animal Back 
3.  Taxi/bus 
4.  Other(specify)_____________ 
 
320 If yes, how long does it take them 
to get the health services site? 
1.  __________hours or   
   ______minutes 
98.  I don’t know 
99.  Refused to tell 
 
 
 
 
 
 
321 If yes, amount of cost for 
transportation? 
1.  ________ Birr 
98.  I don’t know 
99.  Refused to tell 
 
 
322 If yes, amount of cost for other 
expenditures? 
1.  ________ Birr 
98.  I don’t know 
99.  Refused to tell 
 
 
 
                THANK YOU FOR YOUR TIME AND COOPERATION! 
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                ¾eUU’ƒ pê 
           eUU’ƒ  
Ö?“ ÃeÖM˜ እ’@ eT@ ------------------------------------ ÃvLM:: uÔ”Å` Ÿ}T uT>Ñ’–< Ö?“ ×u=Á¨‹ LÃ ¾d”v 
’k`d uISU}™‹“ u›eታTT>­‰†¨< LÃ ¾T>ÁS×¨<” ¾›=¢•T> Ý“ KT¨p uT>"H@Å¨< Ø“ƒ LÃ }dታò ’˜:: 
u;=I Ø“ƒ LÃ uSd}õ­ Ÿõ}— ¾J’ ›É“qƒ Ã•[“M :: K;=I Ø“ƒ Ã[Ç” ;”É 30 Åmn ÑÅT ¾T>¨eÉ ØÁo­‹” 
MÖÃk­ƒ እðMÒKG<:: ¾T>cÖ<” SMe uUeÖ=` ¾T>Öup c=J” eU­”“ ›É^h­” uSÖÃl LÃ ›”ÖpeU::  
u;=I Ø“ƒ LÃ Sd}õ uእ`e­ S<K< ðnÅ˜’ƒ LÃ ¾}Sc[} c=J” ›”É ØÁo ¨ÃU G<K<”U ØÁo­‹” ›KSSKe Ã‹LK<:: ’Ñ` 
Ó” ¾እ`e­ ›e}Á¾ƒ ¨ÃU SMe ÖnT> eKJ’ uØ“~ LÃ Ãd}óK< wK” }eó እ“Å`ÒK”:: 
›G<” eK Ø“~ T“†¨<”U ’Ñ` K=ÖÃl˜ ÃðMÒK<; 
›G<” SÖÃl” SËS` እ‹LKG<”; 
 
SËS]Á c¯ƒ --------------------- SÚ[h c¯ƒ -----------------  k” ----------------- 
 
SMe cÜ¨< (ª) KSÖÃl      SMe cÜ¨< (ª) KSÖÃl 
}eTU}ªM ---------------------     ›M}eTS<U -------------------- 
 
¾S[Í cwdu=¨<(ª) eU -------------------------------------------- ò`T ------------- 
¾}q××]¨< (ª) eU ------------------------------------------- ò`T --------------- 
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¾d”v ’k`d IS<T” ¾SታŸT>Á Ñ”;w SÑS‰ SÖÃp 
}˜}¨< KT>ታŸS< ¾d”v ’k`d IS<T” w‰ 
SÖÃp lØ` ----------------------------- 
¾d”v ’k`d ISU}— SKÁ lØ` ------------------------ 
 
¡õM 1 ›ÖnLÃ ¾ÓKcu< (¾ui}—¨<) S[Í 
101. ï•:-  1. ¨”É ---------------------  2. c?ƒ ----------------------- 
102. °ÉT@:- 1. ------------------------ ¯Sƒ  
       98. ›L¨<k¨<U -----------------------   99. SSKe ›MðMÑ<U ------- 
103. ¾Òw‰ G<’@ታ•:-  
 1. ÁLÑv ---------------    2. ÁÑv (›wa ¾T>•`) ----------------- 
 3. }KÁÃ}¨< ¾T>•\ ------------   4. vLD (T>e~) ¾V}uƒ --------------- 
 5. ¾}óታ(ች)• ------------------------   6. K?L "K ÃÓKê --------------------- 
104. ¾ƒUIƒ`ƒ (ÁÖ“kk/ ÁÖ“kk‹) 
 1. ÁM}T[ -----   2. T”uw“ Síõ w‰ --------  
 3. Ÿ1— -6— ¡õM ---------  4. Ÿ7— -8— ¡õM -------  
 5. Ÿ9— - 12— ¡õM -------  6. ¢K?Ï ¿’>y`e+ -------- 
 7. K?L "K ÃÓKê ----------    
105. K›Kñƒ 12 ¨^ƒ ª’— e^­ U”É” ’¨<; 
 1. e^ ›Ø ----------------       2. Ö<[}— --------------------- 
 3. }T] -------------------      4.. Se^ƒ ¾TÃ‹M / ISU}— --  
      5. ¾u?ƒ እSu?ƒ ---------      6. ’ÒÈ -------------        7. ¾k” 
c^}— --------------      8. ¾S”Óeƒ }k×] ----------      
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 9. ¾ÓM É`Ïƒ }k×] ------------    10. S.Á.É }k×] ---------- 
 11. ¾^c< É`Ïƒ c^}— ÁK<ƒ------  12. ¾^c< É`Ïƒ c^}— ¾K?K<ƒ --- 
 13. u^c< }k×] Ñu_ /›LeÒ] ----  14. K?L "K ÃÓKê ------------- 
106. uu?}cw- ¨<eØ ¾T>Ñ–< ¾c­‹ w<ƒ:-  
 1. ---------------- c­‹  99. S“Ñ` ›MðkÆU --------------- 
107. Ÿu?}cw­ ¨<eØ u›G<’< e”„‡ }k×] “†¨<; ¨ÃU uY^ LÃ ÃÑ—K<; 
 1. ----------------c­‹  99. S“Ñ` ›MðkÆU ------------------ 
108. ¾u?}cw­ ›ÖnLÃ ¨`G© ¾Ñu= SÖ” e”ƒ ’¨<; 
 1. --------------- w` ¨ÃU --------------- ¯Ã’ƒ  
 98. ›L¨<pU  99. S“Ñ` ›MðkÅU -------------------- 
109. ¾እ`e­ ¨`H© ¾Ñu= SÖ” e”ƒ ’¨<; 
 1. ------------ w` ¨ÃU ---------------- u¯Ã’ƒ  
 98. ›L¨<pU --------  99. S“Ñ` ›MðkÆU ---------------------- 
 
¡õM 2   Ÿd”v ’k`d uiታ SK¾ƒ uòƒ ¾T>¨× ¾ªÒ (¾Ñ”;w) SÖ” 
201. ¾d”v ’k`d ui}— J’¨< ¨Å;=I Ö?“ É`Ïƒ ŸSU×ƒ­ uòƒ ¾ISS<  
    UM¡ƒ Ke”ƒ Ñ>;? ›w`­ƒ qÃ…M; 
 1. ------------- k“ƒ   98. ›L¨<pU ----------  99. KS“Ñ` ›MðkÆU----- 
202. uuiታ¨< ¾}’d Ÿe^­ Ke”ƒ k“ƒ k`}ªM; 
 1. ------------- k“ƒ   98. ›L¨<pU ----------  99. KS“Ñ` ›MðkÆU-----. 
203. uiታ¨< ŸSK¾~ uòƒ Ÿe^ Kk\v†¨< k“ƒ U” ÁIM Ñu= (uÑ”;w)  
    ›Ø}ªM; 
 1. -------------- w`  98. ›L¨<pU ---------- 99. KS“Ñ` ›MðkÆU-------- 
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204. uiታ¨< ŸSK¾~ (ŸSታ¨l) uòƒ K?L ›ÑMÓKAƒ cÜ­‹ ›Ã}­ታM;  
     ¾KU ŸJ’ ¨Å ØÁo lØ` 212 ÃH>Æ:-  
 1. ›­ -------------------  2. ¾KU -----------------  
205. KØÁo lØ` 204 SMe ›­ ŸJ’ e”ƒ ¾Ö?“ ›ÑMÓKAƒ cÜ­‹”  
    Ôw˜}ªM; 
 1. ---------------      98. ›L¨<pU ---------- 99. KS“Ñ` ›MðkÆU-------- 
206. U” ›Ã’ƒ ¾Ö?“ ›ÑMÓKAƒ cÜ É`Ïƒ Ôu–<; 
 1. ¾S”Óeƒ  2. ¾S.Á.É ----------------  3. ¾ÓM -------------- 
 4. vIL© ðªi -----      5. K?L "K ÃÑKê --------------  
207. ›ÖnLÃ ¾U¡` ›ÑMÓKAƒ ("`É ÃÚU^M) ¡õÁ  
 1. ---------- w`  98. ›L¨<pU ---------- 99. KS“Ñ` ›MðkÆU-------- 
208. ›ÖnLÃ U`S^ (Lx^„] ¨;}) ¡õÁ:- 
 1. ----------- w`  98. ›L¨<pU ---------- 99. KS“Ñ` ›MðkÆU-------- 
209. ›ÖnLÃ ¾}Ñ< SÉH’>ƒ ªÒ  
 1. ---------- w`  98. ›L¨<pU ---------- 99. KS“Ñ` ›MðkÆU-------- 
210. ¾Ö?“ É`Ï„‹ KSÉ[e U” ›Ã’ƒ ¾SÕÕ: ;È ÃÖkTK<; 
 1. uእÓ`    2. ¾እ”edƒ Ë`v (upKA' ð[e' ¨;}) 
 3. uታ¡c= / u›¨<„u=e  4. K?L "K ÃÑKê----------  
 
211. ¾Ö?“ ›ÑMÓKAƒ cÜ¨< xታ•KSÉ[e U” ÁIM ÃðÌxታM; 
 1. --------------- c¯ƒ ¨ÃU --------- Åmn  
      98. ›L¨<pU ---------- 99.   KS“Ñ` ›MðkÆU--------  
212. ›ÖnLÃ ¾SÕÕ´Á ¡õÁ  
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 1 ----------- w`  98. ›L¨<pU ---------- 99. KS“Ñ` ›MðkÆU-------- 
213. K?KA‹ ›ÖnLÃ ¡õÁ­‹  
 1. ----------- w`  98. ›L¨<pU ---------- 99. KS“Ñ` ›MðkÆU-------- 
214. Ÿ;=I Ö ?“ É`Ïƒ  ŸSU×ƒ­ uòƒ •እ`Çታ• (እ”¡w"u?) ÁÅ[ÑK­ƒ   u?}cw ¨ÃU ÕÅ— ›K; KØÁo lØ` 214 
SMe ¾KU ŸJ’ ¨Å ØÁo lØ` 301 ÃH>Æ 
 1. ›­---------------  2. ¾KU --------------------    
215. KØÁo lØ` 214 SMe ›­” ŸJ’ u?}cw­ ¨ÃU ÕÅ—­ e”ƒ k”  
     Ÿእ`e- Ò` qÃ}ªM; 
 1. ----------- k“ƒ    98. ›L¨<pU ---------- 99. KS“Ñ` ›MðkÆU-------- 
216. KØÁo lØ` 214 SKe­ ›­ ŸJ’ ›ÖnLÃ ¾¨` Ñu=Á†¨< e”ƒ ’¨<; 
 1. ------------ w`    98. ›L¨<pU ---------- 99. KS“Ñ` ›MðkÆU------- 
217. KØÁo lØ` 214 SMe ›­ ŸJ’ እ”¡w"u? ÁÅ[ÑM­ƒ u?}cw ¨Ãe ÕÅ—  
    ¾Ñu= Sk’e ‹Ó` ›ÒØTE†ªM; SMc< ¾KU ŸJ’ ¨Å ØÁo 301 ÃH>Æ 
 1. ›­ -----------   2. ¾KU -----------------  
218. KØÁo lØ` 217 SMe ›­ ŸJ’ Kk\v†¨< k“ƒ U” ÁIM ªÒ (Ñu=)  
    ›Ø}ªM; 
 1. ------------ w`  98. ›L¨<pU ---------- 99. KS“Ñ` ›MðkÆU-------- 
 
219. KØÁo lØ` 217 SMe ›­” ŸJ’ ¾Ö?“ É`Ï„‹ KSÉ[e U” ›Ã’ƒ  
    ¾SÕÕ¹ ²È ÃÖkTK<; 
 1. uእÓ`    2. ¾እ”edƒ Ë`v (upKA' ð[e' ¨;}) 
 3. uታ¡c= / u›¨<„u=e  4. K?L "K ÃÑKê---------- 
220. KØÁo lØ` 217 SMe ›­” ŸJ’ e”ƒ c¯ƒ ÃðÍM; 
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 1. ------------------ c¯ƒ ¨ÃU ----------------- Åmn 
 98. ›L¨<pU ---------- 99. KS“Ñ` ›MðkÆU--------  
221. KØÁo lØ` 217 SMe ›­ ŸJ’ KSÕÕ´ U” ÁIM Ñ”;w ›¨<Ø}ªM; 
 1. ---------- w`  98. ›L¨<pU ---------- 99. KS“Ñ` ›MðkÆU-------- 
222. KØÁo lØ` 217 SMe ›­ ŸJ’ U” ÁIM KK?KA‹ ¨Ü­‹ ›¨<Ø}ªM;  
 1. ----------- w`  98. ›L¨<pU ---------- 99. KS“Ñ` ›MðkÆU--------  
 
¡õM 3     uiታ¨<  Ÿታ¨k u%EL }˜}¨< ¾T>ታŸS< ISU}™‹ ¾T>Á¨Ö<ƒ ¾ªÒ (¾Ñ”;w) SÖ” 
301. uጤና ድርጅቱ U” ÁIM k” qÃ}ªM; 
 1. -------------- k“ƒ  98. ›L¨<pU ---------- 99. KS“Ñ` ›MðkÆU-------- 
302. ጤና ድርጅቱ ላይ uq¿v†¨< k“ƒ ¨<eØ ¾}K¾ ’Ñ` (Kö×' KÒ¨”' K’ÖL ÝT  
      ¨;}) ¾ŸðK<ƒ ’u`;  SMc< ¾KU ŸJ’ ¨Å ØÁo lØ` 304 ÃH>Æ 
 1. ›­”  -------------------  2. ¾KU ----------------------  
303. KØÁo 302 SMe ›­ ŸJ’ U” ÁIM Ñ”;w ›¨Ö<;  
 1. ------------------- w` 98. ›L¨<pU ---------- 99. KS“Ñ` ›MðkÆU------- 
 
304.  uጤና ድርጅቱ }˜}¨< uT>ታŸS<uƒ Ñ>;? Ÿe^ Ke”ƒ k“ƒ k`}ªM; 
 1. ------------------- k”  98. ›L¨<pU ---------- 99. KS“Ñ` ›MðkÆU------- 
305. uጤና ድርጅቱ uS}—ƒ­ (uSJ”­) U¡”Áƒ ÁÖ<ƒ Ñu= Ã•^M; SMc< ¾KU  
     ŸJ’ ¨Å ØÁo 307 ÃH>Æ  
 1. ›­” --------------------- 2. ¾KU -------------------- 
306. KØÁo lØ` 305 SMe ›­ ŸJ’  uk\v†¨< k“ƒ U” ÁIM Ñu=  
     ›Ø}ªM; 
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 1. ------------------- w`  98. ›L¨<pU ---------- 99. KS“Ñ` ›MðkÆU----- 
307. u²=I ጤና ድርጅት Ÿ}–<uƒ k” ËUa KI¡U“' KSÉH’>ƒ ¨ÃU KU`S^  
     ¾ŸðK<ƒ Ñ”;w ’u`; SMc< ¾KU ŸJ’ ¨Å ØÁo lØ` 311 ÃH>Æ:- 
 1. ›­” --------------------- 2. ¾KU --------------------- 
308. KØÁo lØ` 307 SMe ›­” ŸJ’ }˜}¨< uT>ታŸS<uƒ Ñ>;? KSÉH’>ƒ  
     U” ÁIM ŸõKªM; 
 1. -------------- w`  98. ›L¨<pU ---------- 99. KS“Ñ` ›MðkÆU-------- 
309. KØÁo lØ` 307 SMe ›­” ŸJ’ }˜}¨< uT>ታŸS<uƒ Ñ>;? KU`S^  
     U” ÁIM ŸõKªM; 
 1. ------------- w`  98. ›L¨<pU ---------- 99. KS“Ñ` ›MðkÆU-------- 
310. KØÁo lØ` 307 SMe ›­ ŸJ’' }˜}¨< uT>ታŸS<uƒ Ñ>;? U” ÁIM  
   KK?KA‹ ¡õÁ­‹ (KÊ¡}a‹' KSS´Ñu= "`É' KMwe ¨;}..) ›¨<Ø}ªM; 
 1. --------------w`  98. ›L¨<pU ---------- 99. KS“Ñ` ›MðkÆU-------- 
311. KvIM SÉHÉH’>„‹ U” ÁIM ›¨<Ø}ªM; 
 1. ------------- w`  98. ›L¨<pU ---------- 99. KS“Ñ` ›MðkÆU-------- 
312. KK?KA‹ uvKS<Á vMታ;;< SÉH’>„‹ U” ÁIM ŸõKªM; 
 1. ------------- w`  98. ›L¨<pU ---------- 99. KS“Ñ` ›MðkÆU-------- 
313.  uጤና ድርጅቱ }˜}¨< uT>ታŸS<uƒ Ñ>;? •እ`e­ ¨ÃU K=Ôu˜­ƒ ¾S×  
      Kእ`e­ UÓw U” ÁIM ›¨<Ø}ªM;  
 1. ------------- w`  98. ›L¨<pU ---------- 99. KS“Ñ` ›MðkÆU-------- 
314. uጤና ድርጅቱ }˜}¨< uT>ታŸS<uƒ Ñ>;? Ÿu?}cw­ ¨ÃU ŸÕÅ—- እ”¡w"u?   
    ÁÅ[ÑM­ƒ ’u`;  
     1. ›­” --------------------- 2. ¾KU ---------------------  
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315 KØÁo lØ` 314 SMe ›­ ŸJ’ Ÿእ`e­ Ò` uSJ“†¨< Ÿe^ U” ÁIM  
    k” k\;  
 1. -------------- k“ƒ  98. ›L¨<pU ---------- 99. KS“Ñ` ›MðkÆU-------- 
316. KØÁo lØ` 314 SMe ›­ ŸJ’ ¾¨` Ñu=Á†¨< e”ƒ ’¨<; 
 1. -------------- w`   98. ›L¨<pU ---------- 99. KS“Ñ` ›MðkÆU-------- 
317. KØÁo lØ` 314 SMe ›­ ŸJ’ Kእ`e- እ”¡w"u? uTÉ[Ò†¨<  
   ¾T>ÁÖ<ƒ Ñu= ›K;   
1. ›­” --------------------- 2. ¾KU --------------------- 
318. KØÁo lØ` 317 SMe ›­ ŸJ’ Kk\v†¨< k“ƒ U” ÁIM Ñ”;w (ªÒ)  
     Á×K<;  
 1. ------------- w`  98. ›L¨<pU ---------- 99. KS“Ñ` ›MðkÆU-------- 
319. ¾Ö?“ É`Ï„‹ KSÉ[e U” ›Ã’ƒ ¾SÕÕ: ;È ÃÖkTK<; 
 1. uእÓ`    2. ¾እ”edƒ Ë`v (upKA' ð[e' ¨;}) 
 3. uታ¡c= / u›¨<„u=e  4. K?L "K ÃÑKê---------- 
320. ¾Ö?“ ›ÑMÓKAƒ cÜ¨< xታ KSÉ[e U” ÁIM ÃðÌxታM; 
 1. --------------- c¯ƒ ¨ÃU --------- Åmn  
      98. ›L¨<pU ----------   99. KS“Ñ` ›MðkÆU--------  
321. KØÁo lØ` 317 SMe ›­ ŸJ’ KSÕÕ´ U” ÁIM ›¨<Ø}ªM; 
 1. ------------- w`  98. ›L¨<pU ---------- 99. KS“Ñ` ›MðkÆU-------- 
322. KØÁo lØ` 317  SMe ›­ ŸJ’ KK?KA‹ ¨Ü­‹ U” ÁIM  
     ›¨<Ø}ªM; 
 1. -------------- w`  98. ›L¨<pU ---------- 99. KS“Ñ` ›MðkÆU-------- 
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Ñ>;?­” Seª°ƒ ›É`Ñ¨< eK}vu\˜ ›ScÓ“K:: 
 
 
 
 
 
 
